<SEC-DOCUMENT>0001193125-23-237669.txt : 20230919
<SEC-HEADER>0001193125-23-237669.hdr.sgml : 20230919
<ACCEPTANCE-DATETIME>20230919162801
ACCESSION NUMBER:		0001193125-23-237669
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20230915
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230919
DATE AS OF CHANGE:		20230919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alpha Teknova, Inc.
		CENTRAL INDEX KEY:			0001850902
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				943368109
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40538
		FILM NUMBER:		231264182

	BUSINESS ADDRESS:	
		STREET 1:		2451 BERT DRIVE
		CITY:			HOLLISTER
		STATE:			CA
		ZIP:			95023
		BUSINESS PHONE:		8316371100

	MAIL ADDRESS:	
		STREET 1:		2451 BERT DRIVE
		CITY:			HOLLISTER
		STATE:			CA
		ZIP:			95023
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d542885d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tkno="http://www.teknova.com/20230915" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-09-15_to_2023-09-15">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-15_to_2023-09-15">0001850902</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="tkno-20230915.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-15_to_2023-09-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001850902</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-15</xbrli:startDate> <xbrli:endDate>2023-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-15_to_2023-09-15">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Current Report</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt:datemonthdayyearen">September&#160;15, 2023</ix:nonNumeric>)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-09-15_to_2023-09-15">ALPHA TEKNOVA, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-09-15_to_2023-09-15">001-40538</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-09-15_to_2023-09-15">94-3368109</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification No.)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-15_to_2023-09-15">2451 Bert Drive</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-15_to_2023-09-15">Hollister</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-15_to_2023-09-15">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-15_to_2023-09-15">95023</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-09-15_to_2023-09-15">(831)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-09-15_to_2023-09-15">637-1100</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-09-15_to_2023-09-15">Common Stock, par value $0.00001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-09-15_to_2023-09-15">TKNO</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167; 230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR &#167; <span style="white-space:nowrap">240.12b-2).</span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2023-09-15_to_2023-09-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Concurrent Registered Direct Offering and Private Placements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;15, 2023, Alpha Teknova, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Registered Direct Purchase Agreement&#8221;) in connection with a registered direct offering (the &#8220;Registered Direct Offering&#8221;) with certain accredited investors and qualified institutional buyers. On September&#160;15, 2023, the Company also entered into a securities purchase agreement (the &#8220;PIPE Purchase Agreement&#8221; and, together with the Registered Direct Purchase Agreement, the &#8220;Purchase Agreements&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;) in connection with a concurrent private placement (the &#8220;PIPE Private Placement&#8221;) with certain accredited investors and qualified institutional buyers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Registered Direct Purchase Agreement, the Company agreed to offer and sell in the Registered Direct Offering 1,086,485 shares of the Company&#8217;s common stock, $0.00001 par value per share (the &#8220;Common Stock&#8221;) at an offering price of $1.85. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the PIPE Purchase Agreement, the Company agreed to offer and sell in the PIPE Private Placement 11,299,993 shares of Common Stock (the &#8220;PIPE Shares&#8221;), at the same offering price of $1.85. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s controlling stockholder, Telegraph Hill Partners Management Company LLC, through its affiliates Telegraph Hill Partners IV, L.P. and THP IV Affiliates Fund, LLC, its President and Chief Executive Officer and a member of its board of directors, Stephen Gunstream, its Chief Financial Officer, Matthew Lowell, and its General Counsel and Chief Compliance Officer, Damon Terrill, and the Mackowski Family Trust, which is affiliated with J. Matthew Mackowski, a member of the Company&#8217;s board of directors, participated in the PIPE Private Placement and purchased an aggregate of 9,054,052 shares of common stock on the same terms as the other investors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company received aggregate gross proceeds of $22.915&#160;million from the Registered Direct Offering and PIPE Private Placement (collectively, the &#8220;Offerings&#8221;), before deducting offering expenses payable by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Registration Rights Agreement, the Company has agreed to file a registration statement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on or before October&#160;30, 2023 to register for resale the PIPE Shares. The Company shall use its commercially reasonable efforts to cause the registration statement covering the aforementioned securities to be declared effective as promptly as possible after the filing thereof, but in any event no later than the 90th&#160;calendar day following the date of the Registration Rights Agreement (or in the event of a full review by the SEC, the 120th&#160;calendar day following the date of the Registration Rights Agreement). Failure by the Company to meet the filing deadlines and other requirements set forth in the Registration Rights Agreement may subject the Company to certain liquidated damages. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offerings closed on September&#160;19, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 1,086,485 shares of Common Stock sold in the Registered Direct Offering were offered and sold pursuant to a prospectus supplement, dated September&#160;19, 2023, in connection with the Company&#8217;s registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-265987),</span> which registration statement was filed on July&#160;1, 2022 and declared effective on July&#160;12, 2022. A copy of the opinion of Paul Hastings LLP relating to the validity of the securities issued in the Registered Direct Offering is filed herewith as Exhibit 5.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PIPE Shares were offered and sold without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemptions provided by Section&#160;4(a)(2) of the Securities Act and Rule 506 promulgated under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Purchase Agreements and the Registration Rights Agreement are not complete and are qualified in their entirety by references to the full text of the Purchase Agreements and the Registration Rights Agreement, respectively, which are filed as exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> (this &#8220;Current Report&#8221;) and are incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The representations, warranties and covenants made by the Company in any agreement that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements. In addition, the assertions embodied in any representations, warranties and covenants contained in such agreements may be subject to qualifications with respect to knowledge and materiality different from those applicable to security holders generally. Moreover, such representations, warranties or covenants were accurate only as of the date when made, except where expressly stated otherwise. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of the Company&#8217;s affairs at any time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Amendments to the Amended Credit Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;19, 2023, the Company entered into limited waivers and amendments (collectively &#8220;Amendment No.&#160;4&#8221;) to (i)&#160;the May&#160;10, 2022, Amended and Restated Credit and Security Agreement (Term Loan), as amended on November&#160;8, 2022, March&#160;28, 2023, and July&#160;13, 2023, and (ii)&#160;the May&#160;10, 2022, Amended and Restated Credit and Security Agreement (Revolving Loan) as amended on November&#160;8, 2022, March&#160;28, 2023, and July&#160;13, 2023 (together, the &#8220;Amended Credit Agreement&#8221;), in each case with the Company as borrower and with MidCap Financial Trust (&#8220;MidCap&#8221;) as agent and lender, and the additional lenders from time to time party thereto. Amendment No.&#160;4 modifies the credit facility established under the Amended Credit Agreement, consisting of a $52.135&#160;million senior secured term loan (the &#8220;Term Loan&#8221; or, as amended by Amendment No. 4, the &#8220;Amended Term Loan&#8221;) and a $5.0&#160;million working capital facility. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Amended Credit Agreement includes minimum net revenue requirements that are measured on a trailing twelve-month basis and a minimum cash requirement. As previously disclosed, the Company determined that it was not in compliance with the trailing twelve months minimum net revenue covenant as of July&#160;31, 2023. Amendment No. 4 includes a waiver from MidCap of the revenue covenant violation for the period ending July&#160;31, 2023. As a condition to the effectiveness of Amendment No.&#160;4, the Company prepaid the principal amount of the Term Loan in an amount equal to $10.0&#160;million (the &#8220;Term Loan Prepayment&#8221;). Amendment No.&#160;4 reduced these requirements for future periods up to and including for the twelve months ending December&#160;31, 2025&#8212;for example, the Company&#8217;s minimum net revenue requirement was reduced (i)&#160;for the twelve months ending December&#160;31, 2023, from $42.0&#160;million to $36.5&#160;million, (ii)&#160;for the twelve months ending December&#160;31, 2024, from $49.0&#160;million to $42.0&#160;million, and (iii)&#160;for the twelve months ending December&#160;31, 2025, from $58.8&#160;million to $50.0&#160;million. Amendment No.&#160;4 also removed those requirements for the periods ending January&#160;31, 2026 through March&#160;31, 2027, instead requiring that for each applicable twelve-month period ending after December&#160;31, 2025, the Company&#8217;s minimum net revenue requirement will be determined by MidCap in its reasonable discretion in consultation with the Company&#8217;s senior management and based on financial statements and projections delivered to MidCap in accordance with the financial reporting requirements in the Amended Credit Agreement, so long as the minimum net revenue requirements for those periods shall not be less than the greater of (x)&#160;the applicable minimum net revenue requirement for the twelve-month period ending on the last day of the immediately preceding month and (y) $50.0&#160;million. In addition, the minimum cash requirement was reduced from $10.0&#160;million to $9.0&#160;million. Concurrent with Amendment No.&#160;4, the exit fee due on the date of termination of the Amended Term Loan, or the date on which the obligations under the Amended Term Loan become due and payable in full, increased from 8.5% percent to 9.0% of the total aggregate principal amount of term loans made pursuant to the Term Loan (including amendments thereto) as of such date. The Company will not pay a prepayment fee in connection with the Term Loan Prepayment. Finally, Amendment No.&#160;4 conditions the next borrowing under the Revolving Loan on the Company achieving net revenue for the preceding twelve-month period of at least $45.0&#160;million. Other than the modifications described above, the Amended Credit Agreement is unmodified in all other material respects. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary of the amendments comprising Amendment No.&#160;4 does not purport to be complete and is subject to, and qualified in its entirety by, the full text of those amendments, which are filed as exhibits to this Current Report and are incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosures in Item 1.01 of this Current Report regarding the PIPE Shares are incorporated by reference into this Item 3.02. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September 18, 2023, the Company issued a press release announcing the pricing of the Registered Direct Offering and the PIPE Private Placement. On September 19, 2023, the Company issued a press release announcing the closing of the Registered Direct Offering, the PIPE Private Placement and the amendments to the Amended Credit Agreement. Copies of the press releases are filed herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex51.htm">Opinion of Paul Hastings LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex101.htm">Form of Securities Purchase Agreement, dated September 15, 2023 (Registered Direct Offering). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex102.htm">Form of Securities Purchase Agreement, dated September 15, 2023 (PIPE Private Placement). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex103.htm">Form of Registration Rights Agreement, dated September 15, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex104.htm">Limited Waiver and Amendment No.&#160;4 to the Amended and Restated Credit and Security Agreement (Term Loan), by and among Alpha Teknova, Inc. and MidCap Financial Trust, as agent and as a lender, and the additional lenders from time to time party thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex105.htm">Limited Waiver and Amendment No.&#160;4 to the Amended and Restated Credit and Security Agreement (Revolving Loan), by and among Alpha Teknova, Inc. and MidCap Financial Trust, as agent and as a lender, and the additional lenders from time to time party thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex51.htm">Consent of Paul Hastings LLP (included in Exhibit&#160;5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex991.htm">Press Release, dated September&#160;18, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d542885dex992.htm">Press Release, dated September&#160;19, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Non-material&#160;schedules</span> and exhibits have been omitted pursuant to Item 601(a)(5)&#160;of <span style="white-space:nowrap">Regulation&#160;S-K.&#160;The</span> Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">ALPHA TEKNOVA, INC. (Registrant)</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September 19, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ <span style="font-style:italic">Stephen Gunstream</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Stephen Gunstream</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d542885dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g542885g0919013120492.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">September&nbsp;19, 2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">47198.00011</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alpha Teknova, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2451 Bert
Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hollister, CA 95023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to Alpha Teknova, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the preparation and filing
with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) pursuant to Rule 424(b) of the rules and regulations of the Securities Act of 1933, as amended (the &#147;<B><I>Act</I></B>&#148;), of a prospectus supplement,
dated September&nbsp;19, 2023 (the &#147;<B><I>Prospectus Supplement</I></B>&#148;), to the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-265987)</FONT>
originally filed with the Commission under the Act on July&nbsp;1, 2022 (the &#147;<B><I>Registration Statement</I></B>&#148;), and the related prospectus, dated July&nbsp;12, 2022, included in the Registration Statement at the time it originally
became effective (the &#147;<B><I>Base Prospectus</I></B>&#148; and, together with the Prospectus Supplement, the &#147;<B><I>Prospectus</I></B>&#148;), relating to the offering by the Company of 1,086,485 shares (the &#147;<B><I>SPA
Shares</I></B>&#148;) of the Company&#146;s common stock, par value $0.00001 per share (the &#147;<B><I>Common Stock</I></B>&#148;). The SPA Shares are being sold to the accredited investors and qualified institutional buyers named in, and pursuant
to, a securities purchase agreement, dated as of September&nbsp;15, 2023, between the Company and such investors (the &#147;<B><I>Securities Purchase Agreement</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined and relied upon the Registration Statement, the Prospectus, the form of Securities Purchase Agreement, the
Company&#146;s Amended and Restated Certificate of Incorporation, and the Company&#146;s Amended and Restated Bylaws, each as currently in effect, and the originals or copies certified to our satisfaction of such records, documents, certificates,
memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not
independently verified such matters. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In such examination and in rendering the opinions expressed below, we have assumed, without independent investigation or verification: (i)&nbsp;the
genuineness of all signatures on all agreements, instruments, corporate records, certificates and other documents submitted to us; (ii)&nbsp;the legal capacity, competency and authority of all individuals executing documents submitted to us;
(iii)&nbsp;the authenticity and completeness of all agreements, instruments, corporate records, certificates and other documents submitted to us as originals; (iv)&nbsp;that all agreements, instruments, corporate records, certificates and other
documents submitted to us as certified, electronic, facsimile, conformed, photostatic or other copies conform to the originals thereof, and that such originals are authentic and complete; (v)&nbsp;the due authorization, execution and delivery of all
agreements, instruments, corporate records, certificates and other documents by all parties thereto (other than the Company); (vi) that no documents submitted to us have been amended or terminated orally or in writing, except as has been disclosed
to us in writing; (vii)&nbsp;that the Securities Purchase Agreement is the valid and binding obligation of each of the parties thereto, enforceable against such parties in accordance with their terms and that they have not been amended or terminated
orally or in writing; and (viii)&nbsp;that the statements contained in the certificates and comparable documents of public officials, officers and representatives of the Company and other persons on which we have relied for the purposes of this
opinion letter are true and correct on and as of the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g542885g0919013120364.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g542885g0919013120158.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;19, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the
matters expressly stated. Our opinion herein is expressed solely with respect to the federal laws of the United States and the General Corporation Law of the State of Delaware. We are not rendering any opinion as to compliance with any federal or
state antifraud law, rule or regulation relating to securities, or to the sale or issuance thereof. Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or
developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. We express no opinion as to whether the laws of any particular jurisdiction other than those identified above are
applicable to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the SPA Shares, when issued
and sold against payment therefor in accordance with the Securities Purchase Agreement, will be validly issued, fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent
to the reference to our firm under the caption &#147;Legal Matters&#148; in the Prospectus Supplement and to the filing of this opinion as an exhibit to a Current Report of the Company on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Paul Hastings LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d542885dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Securities Purchase Agreement (this &#147;<U>Agreement</U>&#148;) is dated as of September&nbsp;15, 2023, between Alpha Teknova, Inc., a
Delaware corporation (the &#147;<U>Company</U>&#148;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#147;<U>Purchaser</U>&#148; and collectively the &#147;<U>Purchasers</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the
Securities Act, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the
receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section&nbsp;1.1: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiring Person</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.5. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Action</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(j). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board of Directors</U>&#148; means the board of directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day other than Saturday, Sunday or other day on which commercial banks in The City of
New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#147;stay at home&#148;, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;shelter-in-place&#148;,</FONT></FONT> <FONT STYLE="white-space:nowrap">&#147;non-essential</FONT> employee&#148; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the Trading Day on which all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&#146; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&#146;s obligations to deliver the Securities, in each case, have been
satisfied or waived, but in no event later than the second (2nd)&nbsp;Trading Day following the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commission</U>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the common stock of the Company, par value $0.00001&nbsp;per share, and any other class
of securities into which such securities may hereafter be reclassified or changed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock
Equivalents</U>&#148; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Counsel</U>&#148; means Paul Hastings LLP, with offices
located at&nbsp;1117 S. California Avenue, Palo Alto, California&nbsp;94304. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Schedules</U>&#148; means
the Disclosure Schedules of the Company delivered concurrently herewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Time</U>&#148; means,
(i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after&nbsp;9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following
the date of this Agreement, unless otherwise instructed as to an earlier time by the Company, and (ii)&nbsp;if this Agreement is signed between midnight (New York City time) and&nbsp;9:00 a.m. (New York City time) on any Trading Day, no later
than&nbsp;9:01 a.m. (New York City time) on the date of this Agreement, unless otherwise instructed as to an earlier time by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Evaluation Date</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(s). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of&nbsp;1934, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FCPA</U>&#148; means the Foreign Corrupt Practices Act of&nbsp;1977, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(aa). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property Rights</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(p). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> right or other restriction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; shall
have the meaning assigned to such term in Section&nbsp;3.1(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Permits</U>&#148; shall have the meaning
ascribed to such term in Section&nbsp;3.1(n). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Per Share Purchase Price</U>&#148; equals $1.85, subject to
adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Private Placement</U>&#148; means the issuance of securities of the Company pursuant to a private placement entered
into contemporaneously with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proceeding</U>&#148; means an action, claim, suit, investigation or
proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus</U>&#148; means the final base prospectus filed for the Registration Statement, including all information,
documents and exhibits filed with or incorporated by reference into such prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus Supplement</U>&#148; means the supplement to the
Prospectus complying with Rule&nbsp;424(b) of the Securities Act, including all information, documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission and delivered by the
Company to each Purchaser at the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Party</U>&#148; shall have the meaning ascribed to such term
in Section&nbsp;4.7. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; means the effective registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> filed with the Commission (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-265987),</FONT> including all information, documents and exhibits filed with or incorporated by reference into such
registration statement, which registers the sale and issuance of the Securities to the Purchasers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Required
Approvals</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(e). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;144</U>&#148; means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;424</U>&#148; means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC Reports</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities</U>&#148; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of&nbsp;1933, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Short Sales</U>&#148; means all &#147;short sales&#148; as defined in Rule&nbsp;200 of
Regulation&nbsp;SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subscription Amount</U>&#148; means, as to each Purchaser, the aggregate amount to be paid for Securities purchased
hereunder as specified below such Purchaser&#146;s name on the signature page of this Agreement and next to the heading &#147;Subscription Amount,&#148; in United States dollars and in immediately available funds. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any subsidiary of the Company, and shall, where applicable, also include any direct or
indirect subsidiary of the Company formed or acquired after the date of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Day</U>&#148;
means a day on which the principal Trading Market is open for trading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Market</U>&#148; means any of the
following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange
(or any successors to any of the foregoing). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement, all exhibits
and schedules hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer Agent</U>&#148; means Pacific Stock Transfer Company, the current transfer agent of the Company, with a
mailing address of&nbsp;6725 Via Austi Parkway, Suite&nbsp;300, Las Vegas, Nevada&nbsp;89119, and any successor transfer agent of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PURCHASE AND SALE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of $2,009,997.25 of Securities. Each
Purchaser&#146;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &#147;Delivery Versus Payment&#148; (&#147;<U>DVP</U>&#148;)&nbsp;settlement with the Company or its designee. The
Company shall deliver to each Purchaser its respective Securities as determined pursuant to Section&nbsp;2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections&nbsp;2.2 and&nbsp;2.3, the Closing shall occur at the offices of Company Counsel or such other location (including remotely by electronic transmission) upon which the parties may
agree. Unless otherwise directed by the Company, settlement of the Securities shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Securities registered in the Purchasers&#146; names and addresses and released by the Transfer
Agent directly to the account(s) identified by each Purchaser; upon receipt of such Securities, payment therefor shall be made by each Purchaser (or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein to the
contrary, if at any time on or after the time of execution and delivery of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the
&#147;<U><FONT STYLE="white-space:nowrap">Pre-Settlement</FONT> Period</U>&#148;), such Purchaser sells to any Person all, or any portion, of the Securities to be issued hereunder to such Purchaser at the Closing (collectively, the &#147;<U><FONT
STYLE="white-space:nowrap">Pre-Settlement</FONT> Securities</U>&#148;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and
the Company shall be deemed unconditionally bound to sell (in each case subject to the applicable conditions set forth in Sections&nbsp;2.2 and&nbsp;2.3), such <FONT STYLE="white-space:nowrap">Pre-Settlement</FONT> Securities to such Purchaser at
the Closing; provided, that the Company shall not be required to deliver any <FONT STYLE="white-space:nowrap">Pre-Settlement</FONT> Securities to such Purchaser prior to the Company&#146;s receipt of the purchase price of such <FONT
STYLE="white-space:nowrap">Pre-Settlement</FONT> Securities hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not
during the <FONT STYLE="white-space:nowrap">Pre-Settlement</FONT> Period such Purchaser shall sell any shares of Common Stock to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the
time such Purchaser elects to effect any such sale, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Deliveries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On or prior to the Closing Date (except as may be indicated below), the Company shall deliver or cause to be delivered to each Purchaser
the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this Agreement duly executed by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a legal opinion of Company Counsel, directed to the Purchasers, in form and substance reasonably acceptable to the
Purchasers; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) subject to Section&nbsp;2.1, the Company&#146;s wire instructions, on Company letterhead and executed by
the Chief Executive Officer or Chief Financial Officer; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) subject to Section&nbsp;2.1, a copy of the irrevocable
instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&#147;<U>DWAC</U>&#148;) Securities equal to such Purchaser&#146;s
Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Prospectus
and Prospectus Supplement (which may be delivered in accordance with Rule&nbsp;172 under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On or prior to the
Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this Agreement duly
executed by such Purchaser; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) such Purchaser&#146;s Subscription Amount, which shall be made
available for DVP settlement with the Company or its designee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation or warranty is as of a specific date therein, in which case they shall
be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) all obligations, covenants, and agreements of each Purchaser required to be performed at or prior to the Closing Date
shall have been performed; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b) of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following
conditions being met: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the accuracy in all material respects (or, to the extent representations or warranties are
qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation or warranty is as of a specific date therein,
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) all obligations, covenants, and agreements of the Company required to be performed at or prior to the Closing Date shall
have been performed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the delivery by the Company of the items set forth in Section&nbsp;2.2(a) of this Agreement;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) there shall have been no Material Adverse Effect with respect to the Company since the date of this Agreement; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) from the date of this Agreement to the Closing Date, trading in the Common Stock shall not have been suspended by the
Commission or the Company&#146;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities, nor shall there have occurred any material
outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it
impracticable or inadvisable to purchase the Securities at the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND WARRANTIES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Representations and Warranties of the Company</U>. Except as set forth, as applicable, in the SEC Reports and the Disclosure Schedules,
which shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure contained, as applicable, in the corresponding SEC Reports and section of the Disclosure Schedules, and any
other section hereof to the extent that it is readily apparent from a reading of such disclosure that it also qualifies or applies to such other sections, the Company hereby makes the following representations and warranties to each Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Subsidiaries</U>. The Company has no subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Organization and Qualification</U>. The Company is an entity duly incorporated or otherwise organized, validly existing, and in good
standing under the laws of the jurisdiction of its incorporation or organization (if a good standing concept exists in such jurisdiction), with the requisite power and authority to own and use its properties and assets and to carry on its business
as currently conducted. The Company is not in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws, or other organizational or charter documents. The Company is duly qualified to conduct
business and is in good standing (if a good standing concept exists in such jurisdiction) as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing (if a good standing concept exists in such jurisdiction), as the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the
legality, validity, or enforceability of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects, or condition (financial or otherwise) of the Company, taken as a whole, or (iii)&nbsp;a
material adverse effect on the Company&#146;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)&nbsp;or (iii), a &#147;<U>Material Adverse Effect</U>&#148;) and no
Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit, or curtail such power and authority or qualification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the
transactions contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other
Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the
Board of Directors, or the Company&#146;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon
delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will (assuming due authorization, execution, and delivery by other parties thereto) constitute the valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general
application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies and (iii)&nbsp;insofar as indemnification and
contribution provisions may be limited by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Conflicts</U>. The execution, delivery, and performance by the
Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i)&nbsp;conflict with
or violate any provision of the Company&#146;s certificate or articles of incorporation, bylaws, or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company, or give to others any rights of termination, amendment, anti-dilution, or similar adjustments, acceleration or cancellation (with
or without notice, lapse of time or both) of, any agreement, credit facility, debt, or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party, or by which any property or asset of the Company
is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree, or other restriction of any court or governmental authority to which the
Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses&nbsp;(ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Filings, Consents and Approvals</U>. The Company is not required to obtain any
consent, waiver, authorization, or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local, or other governmental authority or other Person in connection with the execution, delivery, and
performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission of the Prospectus Supplement, (iii)&nbsp;the notice and/or
application(s) to each applicable Trading Market for the listing of the Securities for trading thereon in the time and manner required thereby, and (iv)&nbsp;such filings as are required to be made under applicable state securities laws
(collectively, the &#147;<U>Required Approvals</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Issuance of the Securities; Registration</U>. The Securities are duly
authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has prepared and filed
the Registration Statement in conformity with the requirements of the Securities Act, which became effective on July&nbsp;12, 2022, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this
Agreement. The Company was at the time of the filing of the Registration Statement eligible to use <FONT STYLE="white-space:nowrap">Form&nbsp;S-3.</FONT> The Company is eligible to use <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the
Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12)&nbsp;calendar months prior to this offering, as set forth in General
Instruction I.B.6 of <FONT STYLE="white-space:nowrap">Form&nbsp;S-3.</FONT> The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or
preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and
regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule&nbsp;424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the
Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was
issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Capitalization</U>.
The capitalization of the Company is set forth in the SEC Reports. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options or
vesting of restricted stock or restricted stock units under the Company&#146;s stock option or equity plans, the issuance of shares of Common Stock to employees pursuant to the Company&#146;s employee stock purchase plans and pursuant to the
conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents that has not been waived. Except as a result of the purchase and sale of the Securities, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights, or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or
acquire, any shares of Common Stock, or contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the
Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company with any provision that adjusts the exercise,
conversion, exchange, or reset price of such security or instrument upon an issuance of securities by the Company. There are no outstanding securities or instruments of the Company that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings, or arrangements by which the Company is or may become bound to redeem a security of the Company. The Company does not have any stock appreciation rights or &#147;phantom stock&#148; plans or agreements or any
similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid, and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such
outstanding shares was issued in violation of any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors,
or others is required for the issuance and sale of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules,
forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a) or&nbsp;15(d) thereof, for the two (2)&nbsp;years preceding the date of this Agreement
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus
Supplement, being collectively referred to herein as the &#147;<U>SEC Reports</U>&#148;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension,
except where the failure to file on a timely basis would not have or reasonably be expected to result in a Material Adverse Effect. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i) under the Securities Act. The financial statements of the Company included in the SEC
Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#147;<U>GAAP</U>&#148;), except as may be otherwise specified in such financial statements or the notes thereto and except that
unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth in the SEC Reports filed prior to the date of this Agreement, (i)&nbsp;there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material
Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and
(B)&nbsp;liabilities not required to be reflected in the Company&#146;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company
has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)&nbsp;the Company has not issued any
equity securities to any officer, director or Affiliate, except pursuant to existing Company equity plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the
shares of Common Stock contemplated by this Agreement and in the Private Placement or as set forth in the SEC Reports or Schedule 3.1(i), as applicable, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is
reasonably expected to occur or exist with respect to the Company or its business, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time
this representation is made or deemed made that has not been publicly disclosed at least one (1)&nbsp;Trading Day prior to the date that this representation is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Litigation</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(j)</U>, there is no material action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an &#147;<U>Action</U>&#148;). None of the Actions set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(j)</U>, (i)&nbsp;adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. Except as would not be reasonably expected to have a Material Adverse
Effect, there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not
issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Exchange Act or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#146;s employees is a member of a union that relates to such employee&#146;s relationship with the Company, and the Company is not a party to
a collective bargaining agreement, and the Company believes that its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relationships with its employees are good. To the knowledge of the Company, no executive officer of the Company, is, or is now expected to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the
continued employment of each such executive officer does not subject the Company to any liability with respect to any of the foregoing matters that could reasonably be expected to have a Material Adverse Effect. The Company is in compliance with all
U.S.&nbsp;federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance</U>. Except as set forth in the SEC Reports, the
Company is not: (i)&nbsp;in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company under), and the Company has not received written
notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such
default or violation has been waived), (ii)&nbsp;in violation of any judgment, decree or order of any court, arbitrator or other governmental authority, and (iii)&nbsp;has not been in violation of any statute, rule, ordinance or regulation of any
governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each
case of (i), (ii)&nbsp;and (iii)&nbsp;as could not have or reasonably be expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)
<U>Environmental Laws</U>. The Company (i)&nbsp;is in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#147;<U>Hazardous Materials</U>&#148;) into
the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters,
injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#147;<U>Environmental Laws</U>&#148;); (ii)&nbsp;has received all permits licenses or other
approvals required of it under applicable Environmental Laws to conduct its business; and (iii)&nbsp;is in compliance with all terms and conditions of any such permit, license or approval where in each clause&nbsp;(i), (ii)&nbsp;and (iii), the
failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Regulatory
Permits</U>. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct its business as described in the SEC Reports, except where the
failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#147;<U>Material Permits</U>&#148;), and the Company has not received any written notice of proceedings relating to the revocation or
modification of any Material Permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>Title to Assets</U>. The Company has good and marketable title in fee simple to all real
property owned by it and good and marketable title in all personal property owned by it that is material to the business of the Company, free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company, and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Except as would not reasonably be expected to result in a Material Adverse Effect, any real property and facilities held under lease by the Company are held by it
under valid, subsisting and enforceable leases with which the Company is in compliance in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Intellectual
Property</U>. The Company has, or has rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar
rights necessary or required for use in connection with its business as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#147;<U>Intellectual Property Rights</U>&#148;). The
Company has not received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
abandoned, within two (2)&nbsp;years from the date of this Agreement, except for such expirations, terminations or abandonments, which could not reasonably be expected to have a Material Adverse
Effect. The Company has not received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by
another Person of any of the Intellectual Property Rights. The Company has reasonable security measures to protect the secrecy, confidentiality and value of all of its intellectual properties, except where failure to do so could not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Insurance</U>. The Company is insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company is engaged, including, but not limited to, directors and officers insurance coverage in amounts
deemed prudent by the Company. The Company does not have any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
reasonably necessary to continue its business without a significant increase in cost. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <U>Transactions With Affiliates and
Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other than
(i)&nbsp;for services or separation from services as employees, officers and directors or (ii)&nbsp;in connection with the transactions contemplated by this Agreement or the Private Placement), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000
other than for (i)&nbsp;payment of salary or consulting fees for services rendered, (ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option agreements, restricted stock
award agreements or restricted stock unit award agreements under any equity incentive plan of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company is in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of&nbsp;2002, as amended, that are effective as of the date of this Agreement and as of the
Closing Date, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date of this Agreement and as of the Closing Date. The Company maintains a system of internal accounting controls
sufficient to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization, and (iv)&nbsp;the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has established disclosure controls and procedures (as defined in Exchange Act
<FONT STYLE="white-space:nowrap">Rules&nbsp;13a-15(e)</FONT> <FONT STYLE="white-space:nowrap">and&nbsp;15d-15(e))</FONT> for the Company and designed such disclosure controls and procedures to provide reasonable assurance that information required
to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#146;s rules and forms. The Company&#146;s certifying
officers have evaluated the effectiveness of the disclosure controls and procedures of the Company as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#147;<U>Evaluation
Date</U>&#148;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of
the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company that have materially affected, or is reasonably likely to
materially affect, the internal control over financial reporting of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <U>Certain Fees</U>. No brokerage or finder&#146;s
fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.
The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section&nbsp;3.1(t) that may be due in connection with the transactions
contemplated by the Transaction Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <U>Investment Company</U>. The Company is not, and immediately after receipt of payment
for the Securities, will not be, an &#147;investment company&#148; within the meaning of the Investment Company Act of&nbsp;1940, as amended. The Company shall conduct its business in a manner so that it will not become an &#147;investment
company&#148; subject to registration under the Investment Company Act of&nbsp;1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Registration Rights</U>. Except
as set forth in the SEC Reports and other than pursuant to the registration rights agreement to be entered into in connection with the Private Placement, no Person has any right to cause the Company to effect the registration under the Securities
Act of any securities of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to
Section&nbsp;12(b) or&nbsp;12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the
Company received any notification that the Commission is contemplating terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the&nbsp;12&nbsp;months preceding the date of this Agreement, received notice from
any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that
it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established
clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all reasonably necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#146;s certificate of incorporation (or
similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction
Documents, including without limitation as a result of the Company&#146;s issuance of the Securities and the Purchasers&#146; ownership of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents
or the Private Placement, the Company confirms that neither it nor, to the knowledge of the Company, any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes
constitutes or might constitute material, <FONT STYLE="white-space:nowrap">non-public</FONT> information which is not otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the
foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company, its business and the transactions contemplated hereby, including
the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading. The Company acknowledges that, to its knowledge, no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section&nbsp;3.2 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&#146;
representations and warranties set forth in Section&nbsp;3.2, neither the Company, nor any of its Affiliates, and, to the knowledge of the Company, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of
any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i)&nbsp;the Securities Act, or (ii)&nbsp;any
applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <U>Solvency</U>. Based on the consolidated financial condition of the Company as of the
Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&#146;s assets exceeds the amount that will be required to be paid on or in
respect of the Company&#146;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the Company&#146;s assets do not constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and
(iii)&nbsp;the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or
in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in
respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the
Closing Date. The SEC Reports and Schedule 3.1(aa), as applicable, set forth as of the date of this Agreement all outstanding secured and unsecured Indebtedness of the Company, or for which the Company has commitments. For the purposes of this
Agreement, &#147;<U>Indebtedness</U>&#148; means (x)&nbsp;any liabilities for borrowed money or amounts owed by the Company in excess of $150,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all
guaranties, endorsements and other contingent obligations in respect of indebtedness of others to third parties, whether or not the same are or should be reflected in the Company&#146;s consolidated balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $150,000 due under leases required to be
capitalized in accordance with GAAP. The Company is not in default with respect to any Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <U>Tax Status</U>. Except for
matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company (i)&nbsp;has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <U>Foreign Corrupt Practices</U>. Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of
the Company, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or
domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)&nbsp;failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any provision of the FCPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)
<U>Accountants</U>. The Company&#146;s independent registered public accounting firm is Ernst&nbsp;&amp; Young LLP. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is a registered public accounting firm as required by the
Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial statements to be included in the Company&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ending December&nbsp;31,
2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <U>Acknowledgment Regarding Purchasers&#146; Purchase of Securities</U>. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm&#146;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with
the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#146; purchase of the Securities. The Company further represents to each Purchaser that the Company&#146;s decision to enter into this
Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <U>Acknowledgment Regarding Purchaser&#146;s Trading Activity</U>. Notwithstanding
anything in this Agreement or elsewhere herein to the contrary (except for Sections&nbsp;3.2(f) and&nbsp;4.11 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has been asked by the Company to agree, nor
has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#147;derivative&#148; securities based on securities issued by the Company or to hold the Securities for any specified term;
(ii)&nbsp;past (prior to the time at which such Purchaser was first contacted about the transactions contemplated herein) or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or
&#147;derivative&#148; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#146;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties
in &#147;derivative&#148; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#147;short&#148; position in the Common Stock (established prior to the time at which such Purchaser was first contacted
about the transactions contemplated herein), and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&#146;s length counter-party in any &#147;derivative&#148; transaction. The Company further understands
and acknowledges that (y)&nbsp;one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding and (z)&nbsp;such hedging activities (if any) could reduce the value of the existing
stockholders&#146; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction
Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <U>Regulation</U><U></U><U>&nbsp;M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf
has, (i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold, bid
for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&#146;s stock option plan was granted (i)&nbsp;in
accordance with the terms of the Company&#146;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable
law. No stock option granted under the Company&#146;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise
knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its financial results or prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Cybersecurity</U>. (i)(x)&nbsp;Except as set forth in the SEC Reports, to the Company&#146;s knowledge, there has been no security
breach or other compromise of or relating to any of the Company&#146;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party
data maintained by or on behalf of it), equipment or technology (collectively, &#147;<U>IT Systems and Data</U>&#148;) and (y)&nbsp;the Company has not been notified of, and have no knowledge of any event or condition that would reasonably be
expected to result in, any security breach or other compromise to their IT Systems and Data, except as would not, individually or in the aggregate, for all such matters referred to in this clause&nbsp;(i), have a Material Adverse Effect;
(ii)&nbsp;the Company is presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii)&nbsp;the Company has implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems
and Data; and (iv)&nbsp;the Company has implemented backup and disaster recovery technology consistent with commercially reasonable industry standards and practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <U>Office of Foreign Assets Control</U>. Neither the Company nor, to the Company&#146;s knowledge, any director, officer, agent, employee
or affiliate of the Company is currently subject to any U.S.&nbsp;sanctions administered by the Office of Foreign Assets Control of the U.S.&nbsp;Treasury Department (&#147;<U>OFAC</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <U>U.S.</U><U></U><U>&nbsp;Real Property Holding Corporation</U>. The Company is not and has never been a U.S.&nbsp;real property holding
corporation within the meaning of Section&nbsp;897 of the Internal Revenue Code of&nbsp;1986, as amended, and the Company shall so certify upon Purchaser&#146;s request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <U>Bank Holding Company Act</U>. Neither the Company nor any of its Affiliates is
subject to the Bank Holding Company Act of&nbsp;1956, as amended (the &#147;<U>BHCA</U>&#148;) and to regulation by the Board of Governors of the Federal Reserve System (the &#147;<U>Federal Reserve</U>&#148;). Neither the Company nor any of its
Affiliates owns or controls, directly or indirectly, five percent (5%)&nbsp;or more of the outstanding shares of any class of voting securities or twenty-five percent (25%)&nbsp;or more of the total equity of a bank or any entity that is subject to
the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <U>Money Laundering</U>. The operations of the Company are and have been conducted at all times in material compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of&nbsp;1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the
&#147;<U>Money Laundering Laws</U>&#148;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other
Purchaser, hereby represents and warrants as of the date of this Agreement and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in
good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have
been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and
when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#146;s right to sell the Securities pursuant to the
Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date of this Agreement it is,
either: (i)&nbsp;an &#147;accredited investor&#148; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13)&nbsp;under the Securities Act or (ii)&nbsp;a &#147;qualified institutional buyer&#148; as defined in
Rule&nbsp;144A(a) under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of
such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and
conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the Company and its financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses or can acquire without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Company nor any
Affiliate of the Company has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Company nor any Affiliate has made or makes any representation as
to the Company or the quality of the Securities and the Company and any Affiliate may be in possession of <FONT STYLE="white-space:nowrap">non-public</FONT> information with respect to the Company which such Purchaser agrees need not be provided to
it. In connection with the issuance of the Securities to such Purchaser, neither the Company nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not,
nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time
that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution
hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#146;s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#146;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager
that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#146;s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).
Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar
transactions in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>General Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other
general solicitation or general advertisement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and agrees that the representations contained in this
Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&#146;s right to rely on the Company&#146;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall
constitute a representation or warranty, or preclude any actions, except as prohibited by this Agreement, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OTHER
AGREEMENTS OF THE PARTIES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Legends.</U> The Securities shall be issued free of legends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Furnishing of Information</U>. Until the time that no Purchaser owns Securities, the Company shall use commercially reasonable best
efforts to maintain the registration of the Common Stock under Section&nbsp;12(b) or&nbsp;12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date of this Agreement pursuant to the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Integration</U>. The Company shall not sell,
offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and
regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Securities Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by the
Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b)&nbsp;file a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> including the Transaction Documents required
to be filed as exhibits thereto, with the Commission within the time required by the Exchange Act. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior written consent of the Company, with respect to any press release of any Purchaser, or without the prior
consent of each Purchaser, with respect to any press release of the Company (other than the press release described in the first sentence of this Section&nbsp;4.4), which consent shall not unreasonably be withheld or delayed, except if such
disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of
any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;as required by federal securities law in
connection with the filing of final Transaction Documents with the Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of
such disclosure permitted under this clause&nbsp;(b) and reasonably cooperate with such Purchaser regarding such disclosure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#147;<U>Acquiring Person</U>&#148; under any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such
plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Use of Proceeds</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.6</U> attached hereto, the Company shall use the net
proceeds from the sale of the Securities hereunder for general corporate purposes (including for the repayment of a portion of outstanding debt obligations of the Company) and shall not use such proceeds: (a)&nbsp;for the redemption of any Common
Stock or Common Stock Equivalents, except for the repurchase of equity awards and underlying shares of Common Stock from employees and consultants whose service with the Company has terminated, (b)&nbsp;for the settlement of any outstanding
litigation or (c)&nbsp;in violation of FCPA or OFAC regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>Indemnification of Purchasers</U>. Subject to the provisions of
this Section&nbsp;4.7, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#147;<U>Purchaser
Party</U>&#148;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and reasonable expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#146; fees and
costs of investigation that any such Purchaser Party may suffer or incur as a result of or directly relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the
other Transaction Documents, or (b)&nbsp;any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with
respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a material breach of such Purchaser Party&#146;s representations, warranties or covenants under the Transaction Documents or any
agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to
constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in
writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x)&nbsp;the employment thereof has been specifically authorized by the Company in writing,
(y)&nbsp;the Company has failed after a reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period of time to assume such defense and to employ counsel or (z)&nbsp;in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party
under this Agreement (1)&nbsp;for any settlement by a Purchaser Party effected without the Company&#146;s prior written consent, which shall not be unreasonably withheld or delayed; or (2)&nbsp;to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to any Purchaser Party&#146;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The
indemnification required by this Section&nbsp;4.7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred; provided that, if any Purchaser Party is
judicially determined not to be entitled to indemnification or payment under this Section&nbsp;4.7, such Purchaser Party shall promptly reimburse the Company for any payments that are advanced under this sentence. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>Reservation of Common Stock</U>. As of the date of this Agreement, the Company has reserved and the Company shall continue to reserve
and keep available, free of <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Securities pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of
the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Securities on such Trading Market and promptly secure the listing of all of the Securities
on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Securities, and will use commercially reasonable efforts to
cause all of the Securities to be listed or quoted on such other Trading Market as promptly as possible. The Company will then use commercially reasonable efforts to continue the listing and trading of its Common Stock on a Trading Market and will
comply in all respects with the Company&#146;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for
electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in
connection with such electronic transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <U>Equal Treatment of Purchasers</U>. No consideration (including any modification of this
Agreement) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all of the parties to this Agreement. For clarification purposes,
this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the
Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it, will execute any
purchases or sales, including Short Sales, of any of the Company&#146;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly
announced pursuant to the initial press release as described in Section&nbsp;4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly
disclosed by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure
Schedules&nbsp;(other than as disclosed to its legal and other representatives on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis in connection with the transactions contemplated by this
Agreement). Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4,
(ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section&nbsp;4.4, and (iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or any of its officers, directors, employees, Affiliates or agents after the
issuance of the initial press release as described in Section&nbsp;4.4 (in each case, other than to the extent any Purchaser has obligations in any other capacity with respect to the Company). Notwithstanding the foregoing, in the case of a
Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#146;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser&#146;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#146;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the
other parties, if the Closing has not been consummated on or before the fifth (5th)&nbsp;Trading Day following the date of this Agreement; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for any
breach by any other party (or parties). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this
Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for <FONT STYLE="white-space:nowrap">same-day</FONT> processing of any instruction letter delivered by the Company), stamp taxes and other
taxes and duties levied in connection with the delivery of any Securities to the Purchasers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Entire Agreement</U>. The Transaction
Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or
prior to&nbsp;5:30 p.m. (New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages
attached hereto on a day that is not a Trading Day or later than&nbsp;5:30 p.m. (New York City time) on any Trading Day, (c)&nbsp;the second (2nd)&nbsp;Trading Day following the date of mailing, if sent by U.S.&nbsp;nationally recognized overnight
courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least&nbsp;50.1% in interest of the Securities based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers) in any
material respect, the consent of at least&nbsp;50.1% in interest of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Headings</U>. The headings herein are for convenience only, do not constitute a part
of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Successors and Assigns</U>. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &#147;Purchasers.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>No Third-Party
Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Section&nbsp;4.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Governing Law</U>. All questions concerning the construction, validity, enforcement and
interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of law thereof. Each party agrees that all
legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors,
officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of San Francisco, State of California. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of San Francisco, State of California for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents,
then, in addition to the obligations of the Company under Section&nbsp;4.7, the prevailing party in such Action or Proceeding shall be reimbursed by the <FONT STYLE="white-space:nowrap">non-prevailing</FONT> party for its reasonable attorneys&#146;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by <FONT STYLE="white-space:nowrap">e-mail</FONT> delivery (including any electronic signature covered by the
U.S.&nbsp;federal ESIGN Act of&nbsp;2000, Uniform&nbsp;Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall be deemed to have been
duly and validly delivered and shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such &#147;.pdf&#148; signature page were an original thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto
shall use their commercially reasonable efforts to find and employ an alternative </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the
parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein
provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the
Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the
issuance of such replacement Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16 <U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside,
recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or
equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such
enforcement or setoff had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <U>Independent Nature of Purchasers&#146; Obligations and Rights</U>. The obligations of
each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or <FONT STYLE="white-space:nowrap">non-performance</FONT> of
the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a
partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any
other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The Company has elected to
provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision
contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers. Notwithstanding anything to the
contrary in the foregoing, each of the Purchasers has been advised and is being advised by this Agreement to consult with an attorney before executing this Agreement, and each Purchaser has consulted (or had an opportunity to consult) with counsel
of such Purchaser&#146;s choice concerning the terms and conditions of this Agreement and the other Transaction Documents for a reasonable period of time prior to the execution hereof and thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18 <U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking
of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.19 <U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar
transactions of the Common Stock that occur after the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.20 <B><U>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR
PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY.</U></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Pages Follow</I>) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ALPHA TEKNOVA, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Address for Notice:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2451 Bert Dr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hollister, CA&nbsp;95023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen Gunstream</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-Mail</FONT> for Notice: damon.terrill@teknova.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President and Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Hastings LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1117 S. California Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, CA&nbsp;94304 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Jeffrey T. Hartlin, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> jeffhartlin@paulhastings.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE PAGE FOR PURCHASER FOLLOWS] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[PURCHASER SIGNATURE PAGES TO ALPHA TEKNOVA, INC. RD SECURITIES PURCHASE AGREEMENT] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name of
Purchaser:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of
Purchaser:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name of Authorized
Signatory:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title of Authorized
Signatory:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email Address of Authorized
Signatory:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address for Notice to
Purchaser:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subscription Amount:
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities: _________________</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EIN Number: ____________________</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#9744; Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of
the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions
to Closing shall be disregarded, (ii)&nbsp;the Closing shall occur by the second (2nd)&nbsp;Trading Day following the date of this Agreement and (iii)&nbsp;any condition to Closing contemplated by this Agreement (but prior to being disregarded by
clause&nbsp;(i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation
of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d542885dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Securities Purchase Agreement (this &#147;<U>Agreement</U>&#148;) is dated as of September&nbsp;15, 2023, between Alpha Teknova, Inc., a
Delaware corporation (the &#147;<U>Company</U>&#148;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#147;<U>Purchaser</U>&#148; and collectively the &#147;<U>Purchasers</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section&nbsp;4(a)(2) of the Securities Act, and/or
Rule&nbsp;506 of Regulation&nbsp;D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully
described in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and
valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the
following terms have the meanings set forth in this Section&nbsp;1.1: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiring Person</U>&#148; shall have the
meaning ascribed to such term in Section&nbsp;4.5. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Action</U>&#148; shall have the meaning ascribed to such term
in Section&nbsp;3.1(j). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board of Directors</U>&#148; means the board of directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day other than Saturday, Sunday or other day on which commercial banks in The City of
New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#147;stay at home&#148;, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;shelter-in-place&#148;,</FONT></FONT> <FONT STYLE="white-space:nowrap">&#147;non-essential</FONT> employee&#148; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the Trading Day on which all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&#146; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&#146;s obligations to deliver the Securities, in each case, have been
satisfied or waived. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commission</U>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the common stock of the Company, par value $0.00001&nbsp;per share, and any other class
of securities into which such securities may hereafter be reclassified or changed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock
Equivalents</U>&#148; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Counsel</U>&#148; means Paul Hastings LLP, with offices
located at&nbsp;1117 S. California Avenue, Palo Alto, California&nbsp;94304. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Schedules</U>&#148; means
the Disclosure Schedules of the Company delivered concurrently herewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Time</U>&#148; means,
(i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after&nbsp;9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following
the date of this Agreement, unless otherwise instructed as to an earlier time by the Company, and (ii)&nbsp;if this Agreement is signed between midnight (New York City time) and&nbsp;9:00 a.m. (New York City time) on any Trading Day, no later
than&nbsp;9:01 a.m. (New York City time) on the date of this Agreement, unless otherwise instructed as to an earlier time by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; means the earliest of the date that (a)&nbsp;the initial Registration Statement registering
for resale all Securities has been declared effective by the Commission, (b)&nbsp;all of the Securities have been sold pursuant to Rule&nbsp;144 or may be sold pursuant to Rule&nbsp;144 without the requirement for the Company to be in compliance
with the current public information required under Rule&nbsp;144 and without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, (c)&nbsp;following the one year anniversary of the
Closing Date, provided that a holder of Securities is not an Affiliate of the Company, or (d)&nbsp;all of the Securities may be sold pursuant to an exemption from registration under Section&nbsp;4(a)(1) of the Securities Act without volume or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of the
Securities pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Evaluation Date</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(s). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of&nbsp;1934, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FCPA</U>&#148; means the Foreign Corrupt Practices Act of&nbsp;1977, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(bb). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property Rights</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(p). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Legend Removal Date</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.1(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> right or other restriction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; shall
have the meaning assigned to such term in Section&nbsp;3.1(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Permits</U>&#148; shall have the meaning
ascribed to such term in Section&nbsp;3.1(n). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Per Share Purchase Price</U>&#148; equals $1.85, subject to
adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proceeding</U>&#148; means an action, claim, suit, investigation or
proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Party</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.7. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registered Direct</U>&#148; means the issuance of securities of the Company pursuant to a registered direct offering
entered into contemporaneously with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Rights Agreement</U>&#148; means the
Registration Rights Agreement, dated on or about the date of this Agreement, among the Company and the Purchasers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; means a registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Required Approvals</U>&#148; shall
have the meaning ascribed to such term in Section&nbsp;3.1(e). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;144</U>&#148; means
Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and
effect as such Rule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;424</U>&#148; means Rule&nbsp;424 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC Reports</U>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities</U>&#148; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of&nbsp;1933, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Short Sales</U>&#148; means all &#147;short sales&#148; as defined in Rule&nbsp;200 of
Regulation&nbsp;SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subscription Amount</U>&#148; means, as to each Purchaser, the aggregate amount to be paid for Securities purchased
hereunder as specified below such Purchaser&#146;s name on the signature page of this Agreement and next to the heading &#147;Subscription Amount,&#148; in United States dollars and in immediately available funds. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any subsidiary of the Company, and shall, where applicable, also include any direct or
indirect subsidiary of the Company formed or acquired after the date of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Day</U>&#148;
means a day on which the principal Trading Market is open for trading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Market</U>&#148; means any of the
following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange
(or any successors to any of the foregoing). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement, the
Registration Rights Agreement, all exhibits and schedules hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer Agent</U>&#148; means Pacific Stock Transfer Company, the
current transfer agent of the Company, with a mailing address of&nbsp;6725 Via Austi Parkway, Suite&nbsp;300, Las Vegas, Nevada&nbsp;89119, and any successor transfer agent of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE
AND SALE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees
to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of $20,904,987.05 of Securities. Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to such Purchaser&#146;s
Subscription Amount as set forth on the signature page hereto executed by such Purchaser. The Company shall deliver to each Purchaser its respective Securities as determined pursuant to Section&nbsp;2.2(a), and the Company and each Purchaser shall
deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections&nbsp;2.2 and&nbsp;2.3, the Closing shall occur at the offices of Company Counsel or such other
location (including remotely by electronic transmission) upon which the parties may agree. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Deliveries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On or prior to the Closing Date (except as may be indicated below), the Company shall deliver or cause to be delivered to each Purchaser
the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this Agreement duly executed by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a legal opinion of Company Counsel, directed to the Purchasers, in form and substance reasonably acceptable to the
Purchasers; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) subject to Section&nbsp;2.1, the Company&#146;s wire instructions, on Company letterhead and executed by
the Chief Executive Officer or Chief Financial Officer; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a copy of the irrevocable instructions to the Transfer Agent
instructing the Transfer Agent to deliver on an expedited basis a certificate evidencing a number of Securities equal to such Purchaser&#146;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser, or,
at the election of such Purchaser, evidence of the issuance of such Purchaser&#146;s Securities hereunder as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Registration Rights Agreement duly executed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this Agreement duly executed by such Purchaser; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) such Purchaser&#146;s Subscription Amount by wire transfer to the account specified in writing by the Company; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Registration Rights Agreement duly executed by such Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation or warranty is as of a specific date therein, in which case they shall
be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) all obligations, covenants, and agreements of each Purchaser required to be performed at or prior to the Closing Date
shall have been performed; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b) of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following
conditions being met: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the accuracy in all material respects (or, to the extent representations or warranties are
qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation or warranty is as of a specific date therein,
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) all obligations, covenants, and agreements of the Company required to be performed at or prior to the Closing Date shall
have been performed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the delivery by the Company of the items set forth in Section&nbsp;2.2(a) of this Agreement;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) there shall have been no Material Adverse Effect with respect to the Company since the date of this Agreement; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) from the date of this Agreement to the Closing Date, trading in the Common Stock shall not have been suspended by the
Commission or the Company&#146;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities, nor shall there have occurred any material
outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it
impracticable or inadvisable to purchase the Securities at the Closing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Representations and Warranties of the Company</U>. Except as set forth, as applicable, in the SEC Reports and the Disclosure Schedules,
which shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure contained, as applicable, in the corresponding SEC Reports and section of the Disclosure Schedules, and any
other section hereof to the extent that it is readily apparent from a reading of such disclosure that it also qualifies or applies to such other sections, the Company hereby makes the following representations and warranties to each Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Subsidiaries</U>. The Company has no subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Organization and Qualification</U>. The Company is an entity duly incorporated or otherwise organized, validly existing, and in good
standing under the laws of the jurisdiction of its incorporation or organization (if a good standing concept exists in such jurisdiction), with the requisite power and authority to own and use its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
properties and assets and to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions of its respective certificate or articles of
incorporation, bylaws, or other organizational or charter documents. The Company is duly qualified to conduct business and is in good standing (if a good standing concept exists in such jurisdiction) as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing (if a good standing concept exists in such jurisdiction), as the
case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the legality, validity, or enforceability of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations,
assets, business, prospects, or condition (financial or otherwise) of the Company, taken as a whole, or (iii)&nbsp;a material adverse effect on the Company&#146;s ability to perform in any material respect on a timely basis its obligations under any
Transaction Document (any of (i), (ii)&nbsp;or (iii), a &#147;<U>Material Adverse Effect</U>&#148;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting, or curtailing or seeking to revoke, limit, or curtail such power
and authority or qualification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to
enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this
Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is
required by the Company, the Board of Directors, or the Company&#146;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is
a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will (assuming due authorization, execution, and delivery by other parties thereto) constitute the
valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of
general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies and (iii)&nbsp;insofar as
indemnification and contribution provisions may be limited by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Conflicts</U>. The execution, delivery, and
performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i)&nbsp;conflict with or violate any provision of the Company&#146;s certificate or articles of incorporation, bylaws, or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company, or give to others any rights of termination, amendment, anti-dilution, or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt, or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party, or by which
any property or asset of the Company is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree, or other restriction of any court
or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses&nbsp;(ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Filings, Consents, and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization, or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local, or other governmental authority or other
Person in connection with the execution, delivery, and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission
pursuant to the Registration Rights Agreement, (iii)&nbsp;the notice and/or application(s) to each applicable Trading Market for the listing of the Securities for trading thereon in the time and manner required thereby, (iv)&nbsp;the filing of
Form&nbsp;D with the Commission, and (v)&nbsp;such filings as are required to be made under applicable state securities laws (collectively, the &#147;<U>Required Approvals</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Capitalization</U>. The capitalization of the Company is set forth in the SEC
Reports. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options or vesting of restricted stock or restricted stock units under
the Company&#146;s stock option or equity plans, the issuance of shares of Common Stock to employees pursuant to the Company&#146;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding
as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right, right of participation, or any similar right to participate in the
transactions contemplated by the Transaction Documents that has not been waived. Except as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities, rights, or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments,
understandings, or arrangements by which the Company is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock
or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company with any provision that adjusts the exercise, conversion, exchange, or reset price of such security or instrument upon
an issuance of securities by the Company. There are no outstanding securities or instruments of the Company that contain any redemption or similar provisions, and there are no contracts, commitments, understandings, or arrangements by which the
Company is or may become bound to redeem a security of the Company. The Company does not have any stock appreciation rights or &#147;phantom stock&#148; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid, and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors, or others is required for the issuance and sale of the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other
documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a) or&nbsp;15(d) thereof, for the two (2)&nbsp;years preceding the date of this Agreement (or such shorter period as
the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#147;<U>SEC
Reports</U>&#148;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension, except where the failure to file on a timely basis would not have or
reasonably be expected to result in a Material Adverse Effect. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a
consistent basis during the periods involved (&#147;<U>GAAP</U>&#148;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by
GAAP, and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Material Changes; Undisclosed Events, Liabilities
or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth in the SEC Reports filed prior to the date of this Agreement, (i)&nbsp;there has been no event, occurrence or
development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred
in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not required to be reflected in the Company&#146;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the
Company has not altered its method of accounting, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iv)&nbsp;the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity plans. The Company does not have pending before the Commission any request
for confidential treatment of information. Except for the issuance of the shares of Common Stock contemplated by this Agreement and in the Registered Direct or as set forth in the SEC Reports or Schedule 3.1(i), as applicable, no event, liability,
fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its business, prospects, properties, operations, assets or financial condition that would be required to
be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1)&nbsp;Trading Day prior to the date that this representation is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Litigation</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(j)</U>, there is no material action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an &#147;<U>Action</U>&#148;). None of the Actions set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(j)</U>, (i)&nbsp;adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. Except as would not be reasonably expected to have a Material Adverse
Effect, there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not
issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Exchange Act or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#146;s employees is a member of a union that relates to such employee&#146;s relationship with the Company, and the Company is not a party to
a collective bargaining agreement, and the Company believes that its relationships with its employees are good. To the knowledge of the Company, no executive officer of the Company is, or is now expected to be, in violation of any material term of
any employment contract, confidentiality, disclosure or proprietary information agreement or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company to any liability with respect to any of the foregoing matters that could reasonably be expected to have a Material Adverse Effect. The Company is in
compliance with all U.S.&nbsp;federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance</U>. Except as set forth in
the SEC Reports, the Company is not: (i)&nbsp;in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company under), and the Company has
not received written notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii)&nbsp;in violation of any judgment, decree or order of any court, arbitrator or other governmental authority, and (iii)&nbsp;has not been in violation of any statute, rule, ordinance or
regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor
matters, except in each case of (i), (ii)&nbsp;and (iii)&nbsp;as could not have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Environmental Laws</U>. The Company (i)&nbsp;is in compliance with all federal, state, local and foreign laws relating to pollution or
protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &#147;<U>Hazardous Materials</U>&#148;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#147;<U>Environmental
Laws</U>&#148;); (ii)&nbsp;has received all permits licenses or other approvals required of it under applicable Environmental Laws to conduct its business; and (iii)&nbsp;is in compliance with all terms and conditions of any such permit, license or
approval where in each clause&nbsp;(i), (ii)&nbsp;and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Regulatory Permits</U>. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state,
local or foreign regulatory authorities necessary to conduct its business as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#147;<U>Material
Permits</U>&#148;), and the Company has not received any written notice of proceedings relating to the revocation or modification of any Material Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>Title to Assets</U>. The Company has good and marketable title in fee simple to all real property owned by it and good and marketable
title in all personal property owned by it that is material to the business of the Company, free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially interfere with the use
made and proposed to be made of such property by the Company, and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither
delinquent nor subject to penalties. Except as would not reasonably be expected to result in a Material Adverse Effect, any real property and facilities held under lease by the Company are held by it under valid, subsisting and enforceable leases
with which the Company is in compliance in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Intellectual Property</U>. The Company has, or has rights to
use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in
connection with its business as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#147;<U>Intellectual Property Rights</U>&#148;). The Company has not received a notice (written or
otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years from the date of this Agreement, except for such expirations,
terminations or abandonments, which could not reasonably be expected to have a Material Adverse Effect. The Company has not received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a
claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company has taken reasonable security measures to protect the secrecy, confidentiality and
value of all of its intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Insurance</U>. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company is engaged, including, but not limited to, directors and officers insurance coverage in amounts deemed prudent by the Company. The Company does not have any reason to
believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be reasonably necessary to continue its business without a significant increase in
cost. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of
the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other than (i)&nbsp;for services or separation from services as employees, officers and directors or
(ii)&nbsp;in connection with the transactions contemplated by this Agreement or the Registered Direct), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer,
director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option agreements, restricted stock award agreements or restricted stock unit award agreements under any equity incentive
plan of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company is in compliance in all
material respects with any and all applicable requirements of the Sarbanes-Oxley Act of&nbsp;2002, as amended, that are effective as of the date of this Agreement and as of the Closing Date, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date of this Agreement and as of the Closing Date. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that:
(i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization, and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. The Company has established disclosure controls and procedures (as defined in Exchange Act <FONT STYLE="white-space:nowrap">Rules&nbsp;13a-15(e)</FONT>
<FONT STYLE="white-space:nowrap">and&nbsp;15d-15(e))</FONT> for the Company and designed such disclosure controls and procedures to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or
submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#146;s rules and forms. The Company&#146;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#147;<U>Evaluation Date</U>&#148;). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no
changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <U>Certain Fees</U>. No brokerage or finder&#146;s fees or commissions are or will be payable by the Company to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with
respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section&nbsp;3.1(t) that may be due in connection with the transactions contemplated by the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <U>Private Placement</U>. Assuming the accuracy of the Purchasers&#146; representations and warranties set forth in Section&nbsp;3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the applicable rules and
regulations of the Trading Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Investment Company</U>. The Company is not, and immediately after receipt of payment for the
Securities, will not be, an &#147;investment company&#148; within the meaning of the Investment Company Act of&nbsp;1940, as amended. The Company shall conduct its business in a manner so that it will not become an &#147;investment company&#148;
subject to registration under the Investment Company Act of&nbsp;1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <U>Registration Rights</U>. Except as set forth in
the SEC Reports and other than to each of the Purchasers pursuant to the Registration Rights Agreement, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section&nbsp;12(b) or&nbsp;12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the
Commission is contemplating terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the&nbsp;12&nbsp;months preceding the date of this Agreement, received notice from any Trading Market on which the Common
Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future
continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is
current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <U>Application of Takeover Protections</U>. The Company and the Board of Directors have
taken all reasonably necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the
Company&#146;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or
exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#146;s issuance of the Securities and the Purchasers&#146; ownership of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents
or the Registered Direct, the Company confirms that neither it nor, to the knowledge of the Company, any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes
constitutes or might constitute material, <FONT STYLE="white-space:nowrap">non-public</FONT> information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of
the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company, its business and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in
all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not
misleading. The Company acknowledges that, to its knowledge, no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&#146; representations and warranties set forth in
Section&nbsp;3.2, neither the Company, nor any of its Affiliates, and, to the knowledge of the Company, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy
any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i)&nbsp;the Securities Act that would require the registration of the Securities under the
Securities Act, or (ii)&nbsp;any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&#146;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#146;s existing debts and
other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the Company&#146;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its
capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)&nbsp;the current cash flow of the Company,
together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of
any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports and Schedule 3.1(bb), as
applicable, set forth as of the date of this Agreement all outstanding secured and unsecured Indebtedness of the Company, or for which the Company has commitments. For the purposes of this Agreement, &#147;<U>Indebtedness</U>&#148; means
(x)&nbsp;any liabilities for borrowed money or amounts owed by the Company in excess of $150,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties, endorsements and other contingent obligations
in respect of indebtedness of others to third parties, whether or not the same are or should be reflected in the Company&#146;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit
or collection or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $150,000 due under leases required to be capitalized in accordance with GAAP. The Company is not in default
with respect to any Indebtedness. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <U>Tax Status</U>. Except for matters that would not, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect, the Company (i)&nbsp;has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on
its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <U>No General
Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the
Purchasers and certain other &#147;accredited investors&#148; within the meaning of Rule&nbsp;501 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee)
<U>Foreign Corrupt Practices</U>. Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii)&nbsp;failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any
provision of the FCPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <U>Accountants</U>. The Company&#146;s independent registered public accounting firm is Ernst&nbsp;&amp;
Young LLP. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is a registered public accounting firm as required by the Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial statements to be
included in the Company&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ending December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <U>Acknowledgment Regarding Purchasers&#146; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&#146;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the
Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#146; purchase of the Securities. The Company further represents to each Purchaser that the Company&#146;s decision to enter into this Agreement
and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <U>Acknowledgment Regarding Purchaser&#146;s Trading Activity</U>. Notwithstanding anything in this Agreement or elsewhere herein to the
contrary (except for Sections&nbsp;3.2(f) and&nbsp;4.11 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing
or selling, long and/or short, securities of the Company, or &#147;derivative&#148; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii)&nbsp;past (prior to the time at which such Purchaser was
first contacted about the transactions contemplated herein) or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#147;derivative&#148; transactions, before or after the closing of
this or future private placement transactions, may negatively impact the market price of the Company&#146;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties in &#147;derivative&#148; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &#147;short&#148; position in the Common Stock (established prior to the time at which such Purchaser was first contacted about the transactions contemplated herein), and (iv)&nbsp;each
Purchaser shall not be deemed to have any affiliation with or control over any arm&#146;s length counter-party in any &#147;derivative&#148; transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may
engage in hedging activities at various times during the period that the Securities are outstanding and (z)&nbsp;such hedging activities (if any) could reduce the value of the existing stockholders&#146; equity interests in the Company at and after
the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Regulation</U><U></U><U>&nbsp;M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has,
(i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold, bid for,
purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <U>Stock Option Plans</U>. Each stock option granted by the Company under the
Company&#146;s stock option plan was granted (i)&nbsp;in accordance with the terms of the Company&#146;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option
would be considered granted under GAAP and applicable law. No stock option granted under the Company&#146;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to
knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its financial results or prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <U>Cybersecurity</U>. (i)(x)&nbsp;Except as set forth in the SEC Reports, to the Company&#146;s knowledge, there has been no security
breach or other compromise of or relating to any of the Company&#146;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party
data maintained by or on behalf of it), equipment or technology (collectively, &#147;<U>IT Systems and Data</U>&#148;) and (y)&nbsp;the Company has not been notified of, and have no knowledge of any event or condition that would reasonably be
expected to result in, any security breach or other compromise to their IT Systems and Data, except as would not, individually or in the aggregate, for all such matters referred to in this clause&nbsp;(i), have a Material Adverse Effect;
(ii)&nbsp;the Company is presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii)&nbsp;the Company has implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems
and Data; and (iv)&nbsp;the Company has implemented backup and disaster recovery technology consistent with commercially reasonable industry standards and practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <U>Office of Foreign Assets Control</U>. Neither the Company nor, to the Company&#146;s knowledge, any director, officer, agent, employee
or affiliate of the Company is currently subject to any U.S.&nbsp;sanctions administered by the Office of Foreign Assets Control of the U.S.&nbsp;Treasury Department (&#147;<U>OFAC</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <U>U.S.</U><U></U><U>&nbsp;Real Property Holding Corporation</U>. The Company is not and has never been a U.S.&nbsp;real property holding
corporation within the meaning of Section&nbsp;897 of the Internal Revenue Code of&nbsp;1986, as amended, and the Company shall so certify upon Purchaser&#146;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) <U>Bank Holding Company Act</U>. Neither the Company nor any of its Affiliates is subject to the Bank Holding Company Act of&nbsp;1956,
as amended (the &#147;<U>BHCA</U>&#148;) and to regulation by the Board of Governors of the Federal Reserve System (the &#147;<U>Federal Reserve</U>&#148;). Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five
percent (5%)&nbsp;or more of the outstanding shares of any class of voting securities or twenty-five percent (25%)&nbsp;or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <U>Money Laundering</U>. The operations of the Company are and have been conducted at all times in material compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of&nbsp;1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the
&#147;<U>Money Laundering Laws</U>&#148;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in
reliance on Rule&nbsp;506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner
of&nbsp;20% or more of the Company&#146;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the Securities Act) connected with the Company in any capacity
at the time of sale (each, an &#147;<U>Issuer Covered Person</U>&#148;) is subject to any of the &#147;Bad Actor&#148; disqualifications </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
described in Rule&nbsp;506(d)(1)(i) to (viii)&nbsp;under the Securities Act (a &#147;<U>Disqualification Event</U>&#148;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2) or
(d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e), and
has furnished to the Purchasers a copy of any disclosures provided thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <U>Other Covered Persons</U>. The Company is not
aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <U>Notice of Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i)&nbsp;any
Disqualification Event relating to any Issuer Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is
aware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby
represents and warrants as of the date of this Agreement and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in
good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have
been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and
when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#146;s right to sell the Securities pursuant to the
Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the Securities are
&#147;restricted securities&#148; and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing
or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this
representation and warranty not limiting such Purchaser&#146;s right to sell such Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date of this Agreement it is,
either: (i)&nbsp;an &#147;accredited investor&#148; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13)&nbsp;under the Securities Act or (ii)&nbsp;a &#147;qualified institutional buyer&#148; as defined in
Rule&nbsp;144A(a) under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of
such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and
conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the Company and its financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed
investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Company nor any Affiliate of the Company has provided such Purchaser with any information or advice with respect to the Securities nor is
such information or advice necessary or desired. Neither the Company nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Company and any Affiliate may be in possession of <FONT
STYLE="white-space:nowrap">non-public</FONT> information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Company nor any of its
Affiliates has acted as a financial advisor or fiduciary to such Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Certain Transactions and Confidentiality</U>. Other
than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of
the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&#146;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#146;s assets, the representation set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#146;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating
or borrowing shares in order to effect Short Sales or similar transactions in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>General Solicitation</U>. Such Purchaser
is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and
agrees that the representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&#146;s right to rely on the Company&#146;s representations and warranties contained in this Agreement or any representations and
warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, except as prohibited by this Agreement, with respect to locating or borrowing shares in order to effect Short Sales or similar
transactions in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER AGREEMENTS OF THE PARTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the
Securities other than pursuant to an effective registration statement or Rule&nbsp;144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section&nbsp;4.1(b), the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall
have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Purchasers agree to
the imprinting, so long as is required by this Section&nbsp;4.1, of a legend on any of the Securities substantially in the following form: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF&nbsp;1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT&nbsp;UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#147;ACCREDITED INVESTOR&#148; AS DEFINED IN RULE&nbsp;501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#147;accredited investor&#148; as defined in Rule&nbsp;501(a) under the Securities Act and, if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party
or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&#146;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party
of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, to the extent the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any
required prospectus supplement under Rule&nbsp;424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement)
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Certificates evidencing the Securities shall not contain any legend (including the legend set forth in
Section&nbsp;4.1(b) hereof): (i)&nbsp;while a registration statement&nbsp;(including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii)&nbsp;following any sale of such Securities pursuant to
Rule&nbsp;144, (iii)&nbsp;if such Securities are eligible for sale under Rule&nbsp;144, without the requirement for the Company to be in compliance with the current public information required under Rule&nbsp;144 as to such Securities and without
volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, or (iv)&nbsp;if such legend is not required under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section&nbsp;4.1(c), the Company will, no
later than the earlier of (i)&nbsp;three (3)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a
certificate representing Securities issued with a restrictive legend (such date, the &#147;<U>Legend Removal Date</U>&#148;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive
and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section&nbsp;4. Certificates for Securities subject to legend removal
hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#146;s prime broker with the Depository Trust Company System as directed by such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchaser. As used herein, &#147;Standard Settlement Period&#148; means the standard settlement period, expressed in a number of Trading Days, on the Company&#146;s primary Trading Market with
respect to the Common Stock as in effect on the date of delivery of a certificate representing Securities issued with a restrictive legend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in
compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section&nbsp;4.1 is predicated upon the Company&#146;s reliance
upon this understanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Furnishing of Information; Public Information</U>. Until the time that no Purchaser owns Securities, the
Company shall use commercially reasonable best efforts to maintain the registration of the Common Stock under Section&nbsp;12(b) or&nbsp;12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the
applicable grace period) all reports required to be filed by the Company after the date of this Agreement pursuant to the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated
with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Securities Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by the
Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b)&nbsp;file a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> including the Transaction Documents required
to be filed as exhibits thereto, with the Commission within the time required by the Exchange Act. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior written consent of the Company, with respect to any press release of any Purchaser, or without the prior
consent of each Purchaser, with respect to any press release of the Company (other than the press release described in the first sentence of this Section&nbsp;4.4), which consent shall not unreasonably be withheld or delayed, except if such
disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of
any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;as required by federal securities law in
connection with (i)&nbsp;any registration statement contemplated by the Registration Rights Agreement and (ii)&nbsp;the filing of final Transaction Documents with the Commission and (b)&nbsp;to the extent such disclosure is required by law or
Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause&nbsp;(b) and reasonably cooperate with such Purchaser regarding such disclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &#147;<U>Acquiring Person</U>&#148; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or
hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and
the Purchasers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Use of Proceeds</U>. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;4.6</U> attached hereto, the Company
shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes (including for the repayment of a portion of outstanding debt obligations of the Company) and shall not use such proceeds: (a)&nbsp;for the
redemption of any Common Stock or Common Stock Equivalents, except for the repurchase of equity awards and underlying shares of Common Stock from employees and consultants whose service with the Company has terminated, (b)&nbsp;for the settlement of
any outstanding litigation or (c)&nbsp;in violation of FCPA or OFAC regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>Indemnification of Purchasers</U>. Subject to the provisions of this
Section&nbsp;4.7, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#147;<U>Purchaser
Party</U>&#148;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and reasonable expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#146; fees and
costs of investigation that any such Purchaser Party may suffer or incur as a result of or directly relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the
other Transaction Documents, or (b)&nbsp;any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with
respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a material breach of such Purchaser Party&#146;s representations, warranties or covenants under the Transaction Documents or any
agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to
constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in
writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x)&nbsp;the employment thereof has been specifically authorized by the Company in writing,
(y)&nbsp;the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z)&nbsp;in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this
Agreement (1)&nbsp;for any settlement by a Purchaser Party effected without the Company&#146;s prior written consent, which shall not be unreasonably withheld or delayed; or (2)&nbsp;to the extent, but only to the extent that a loss, claim, damage
or liability is attributable to any Purchaser Party&#146;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required
by this Section&nbsp;4.7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred; provided that, if any Purchaser Party is judicially determined not
to be entitled to indemnification or payment under this Section&nbsp;4.7, such Purchaser Party shall promptly reimburse the Company for any payments that are advanced under this sentence. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>Reservation of Common Stock</U>. As of the date of this Agreement, the Company has reserved and the Company shall continue to reserve
and keep available, free of <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Securities pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of
the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Securities on such Trading Market and promptly secure the listing of all of the Securities
on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Securities, and will use commercially reasonable efforts to
cause all of the Securities to be listed or quoted on such other Trading Market as promptly as possible. The Company will then use commercially reasonable efforts to continue the listing and trading of its Common Stock on a Trading Market and will
comply in all respects with the Company&#146;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for
electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in
connection with such electronic transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <U>Equal Treatment of Purchasers</U>. No consideration (including any modification of
this Agreement) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all of the parties to this Agreement. For clarification
purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as
the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it, will execute any
purchases or sales, including Short Sales, of any of the Company&#146;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly
announced pursuant to the initial press release as described in Section&nbsp;4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly
disclosed by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure
Schedules&nbsp;(other than as disclosed to its legal and other representatives on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis in connection with the transactions contemplated by this
Agreement). Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4,
(ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are
first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4, and (iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or any of its
officers, directors, employees, Affiliates or agents after the issuance of the initial press release as described in Section&nbsp;4.4 (in each case, other than to the extent any Purchaser has obligations in any other capacity with respect to the
Company). Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#146;s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#146;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.12 <U>Form</U><U></U><U>&nbsp;D; Blue Sky
Filings</U>. If required, the Company agrees to timely file a Form&nbsp;D with respect to the Securities as required under Regulation&nbsp;D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as
the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &#147;Blue Sky&#148; laws of the states of the United
States, and shall provide evidence of such actions promptly upon request of any Purchaser. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#146;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the
other parties, if the Closing has not been consummated on or before the fifth (5th)&nbsp;Trading Day following the date of this Agreement; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for any
breach by any other party (or parties). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this
Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for <FONT STYLE="white-space:nowrap">same-day</FONT> processing of any instruction letter delivered by the Company), stamp taxes and other
taxes and duties levied in connection with the delivery of any Securities to the Purchasers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and
schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Notices</U>. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via email attachment at the
email address as set forth on the signature pages attached hereto at or prior to&nbsp;5:30 p.m. (New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered via
email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than&nbsp;5:30 p.m. (New York City time) on any Trading Day, (c)&nbsp;the second (2nd)&nbsp;Trading Day following
the date of mailing, if sent by U.S.&nbsp;nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth
on the signature pages attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified,
supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least&nbsp;50.1% in interest of the Securities based on the initial Subscription Amounts hereunder (or,
prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely
impacts a Purchaser (or group of Purchasers) in any material respect, the consent of at least&nbsp;50.1% in interest of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or
omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding upon each
Purchaser and holder of Securities and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Headings</U>. The headings herein are for convenience only, do not constitute
a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Successors and Assigns</U>. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &#147;Purchasers.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>No Third-Party
Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Section&nbsp;4.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Governing Law</U>. All questions concerning the construction, validity, enforcement and
interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of law thereof. Each party agrees that all
legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors,
officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of San Francisco, State of California. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of San Francisco, State of California for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is
improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to
the obligations of the Company under Section&nbsp;4.7, the prevailing party in such Action or Proceeding shall be reimbursed by the <FONT STYLE="white-space:nowrap">non-prevailing</FONT> party for its reasonable attorneys&#146; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it
being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by <FONT STYLE="white-space:nowrap">e-mail</FONT> delivery (including any electronic signature covered by the U.S.&nbsp;federal ESIGN
Act of&nbsp;2000, Uniform&nbsp;Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall be deemed to have been duly and validly
delivered and shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such &#147;.pdf&#148; signature page were an original thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall
use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be
the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein
provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the
Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the
issuance of such replacement Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16 <U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to
any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to
be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy
law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <U>Independent Nature of Purchasers&#146; Obligations and
Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or <FONT
STYLE="white-space:nowrap">non-performance</FONT> of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or
thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such
obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is
expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and
among the Purchasers. Notwithstanding anything to the contrary in the foregoing, each of the Purchasers has been advised and is being advised by this Agreement to consult with an attorney before executing this Agreement, and each Purchaser has
consulted (or had an opportunity to consult) with counsel of such Purchaser&#146;s choice concerning the terms and conditions of this Agreement and the other Transaction Documents for a reasonable period of time prior to the execution hereof and
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18 <U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of
any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.19 <U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar
transactions of the Common Stock that occur after the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.20 <B><U>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR
PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY</U></B><B>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Pages Follow</I>) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ALPHA TEKNOVA, INC. </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Address for Notice: <BR>Attention: General Counsel <BR>2451 Bert Dr.&nbsp;<BR>Hollister, CA&nbsp;95023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen Gunstream</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="white-space:nowrap">E-Mail</FONT> for Notice: damon.terrill@teknova.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President and Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Hastings LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1117 S. California Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, CA&nbsp;94304 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Jeffrey T. Hartlin, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> jeffhartlin@paulhastings.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE PAGE FOR PURCHASER FOLLOWS] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[PURCHASER SIGNATURE PAGES TO ALPHA TEKNOVA, INC. PIPE SECURITIES PURCHASE AGREEMENT] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Purchaser: ________________________________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of Purchaser</I>: _________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Authorized Signatory: _______________________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Authorized Signatory: ________________________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email Address of Authorized Signatory:_________________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notice to Purchaser:_______________________________________________ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Delivery of Securities to Purchaser (if not same as address for notice):_______ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subscription Amount: $_________________ </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities:
_________________ </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EIN Number: ____________________ </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>d542885dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Registration Rights Agreement (this &#147;<U>Agreement</U>&#148;) is made and entered into as of September&nbsp;15, 2023, by and between
Alpha Teknova, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and each of the several purchasers signatory hereto (each such purchaser, a &#147;<U>Purchaser</U>&#148; and, collectively, the &#147;<U>Purchasers</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the
&#147;<U>Purchase Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and each Purchaser hereby agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms
in the Purchase Agreement</B>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Advice</U>&#148; shall have the meaning set forth in Section&nbsp;6(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effectiveness Date</U>&#148; means, with respect to the Initial Registration Statement required to be filed hereunder,
the&nbsp;90th calendar day following the date hereof (or, in the event of a &#147;full review&#148; by the Commission, the&nbsp;120th calendar day following the date hereof) and with respect to any additional Registration Statements which may be
required pursuant to Section&nbsp;2(c) or Section&nbsp;3(c), the&nbsp;90th calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a &#147;full review&#148; by the
Commission, the&nbsp;120th calendar day following the date such additional Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that one or more of
the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so
notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effectiveness Period</U>&#148; shall have the meaning set forth in Section&nbsp;2(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Filing Date</U>&#148; means, with respect to the Initial Registration Statement required hereunder, the&nbsp;45th
calendar day following the date hereof (or, if such deadline falls on a weekend or federal holiday, then the next business day thereafter) and, with respect to any additional Registration Statements which may be required pursuant to
Section&nbsp;2(c) or Section&nbsp;3(c), the earliest practicable date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>&#148; or &#147;<U>Holders</U>&#148; means the holder or holders, as the case may be, from time to time of
Registrable Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnified Party</U>&#148; shall have the meaning set forth in
Section&nbsp;5(c). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnifying Party</U>&#148; shall have the meaning set forth in Section&nbsp;5(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Initial Registration Statement</U>&#148; means the initial Registration Statement filed pursuant to this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Losses</U>&#148; shall have the meaning set forth in Section&nbsp;5(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Plan of Distribution</U>&#148; shall have the meaning set forth in Section&nbsp;2(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus</U>&#148; means the prospectus included in a Registration Statement&nbsp;(including, without limitation, a
prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule&nbsp;430A promulgated by the Commission pursuant to the Securities Act), as amended or
supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including
post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registrable Securities</U>&#148; means, as of any date of determination, (a)&nbsp;all Securities issued by the Company
to each Purchaser pursuant the Purchase Agreement and (b)&nbsp;any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <U>provided,</U>
<U>however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so
long as (x)&nbsp;a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with
such effective Registration Statement, (y)&nbsp;such Registrable Securities have been previously sold in accordance with Rule&nbsp;144, or (z)&nbsp;such securities become eligible for resale without volume or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions and without current public information pursuant to Rule&nbsp;144 as set forth in a written opinion letter to such effect, addressed, delivered and reasonably acceptable to the
Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; means any registration statement required to be filed hereunder pursuant to
Section&nbsp;2(a) and any additional registration statements contemplated by Section&nbsp;2(c) or Section&nbsp;3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or Prospectus, including <FONT
STYLE="white-space:nowrap">pre-</FONT> and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;415</U>&#148; means Rule&nbsp;415
promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as
such Rule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule</U><U></U><U>&nbsp;424</U>&#148; means Rule&nbsp;424 promulgated by the Commission pursuant to
the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Selling Stockholder Questionnaire</U>&#148; shall have the meaning set forth in Section&nbsp;3(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC Guidance</U>&#148; means (i)&nbsp;any publicly-available written or oral guidance of the Commission staff, or any
comments, requirements or requests of the Commission staff and (ii)&nbsp;the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.<U> Shelf Registration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering
the resale of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule&nbsp;415. Each Registration Statement filed hereunder shall be on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> or <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (to the extent the Company is not then eligible to register for resale the Registrable Securities on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section&nbsp;2(d)) and shall contain (unless otherwise directed by at least&nbsp;85%
in interest of the Holders) substantially the &#147;<U>Plan of Distribution</U>&#148;, in the form attached hereto as <U>Annex</U><U></U><U>&nbsp;A,</U> and substantially the &#147;<U>Selling Stockholders</U>&#148; section, in substantially the form
attached hereto as <U>Annex</U><U></U><U>&nbsp;B</U>; <U>provided</U>, <U>however</U>, that no Holder shall be required to be named as an &#147;underwriter&#148; without such Holder&#146;s express prior written consent. Subject to the terms of this
Agreement, the Company shall use its commercially reasonable efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section&nbsp;3(c)) to be declared effective under the Securities Act as promptly
as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act until the
date that all Registrable Securities covered by such Registration Statement&nbsp;(i) have been sold, thereunder or pursuant to Rule&nbsp;144, or (ii)&nbsp;may be sold without volume or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule&nbsp;144 and without the requirement for the Company to be in compliance with the current public information requirement
under Rule&nbsp;144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and reasonably acceptable to the Transfer Agent and the affected Holders (the &#147;<U>Effectiveness Period</U>&#148;).
The Company shall request effectiveness of a Registration Statement telephonically or by submitting a request for acceleration in accordance with Rule&nbsp;461 promulgated pursuant to the Securities Act, in either case as of&nbsp;5:00 p.m. (New York
City time) on a Trading Day. The Company shall notify the Holders via <FONT STYLE="white-space:nowrap">e-mail</FONT> of the effectiveness of a Registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Statement within two (2)&nbsp;Trading Days after the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration
Statement. The Company shall, by&nbsp;9:30 a.m. (New York City time) by the second (2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>) Trading Day after the effective date of such Registration Statement, file a final Prospectus with the
Commission as required by Rule&nbsp;424. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the registration obligations set forth in Section&nbsp;2(a),
if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule&nbsp;415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly
inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered
by the Commission, on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1,</FONT> <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the
provisions of Section&nbsp;2(d); with respect to filing on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1,</FONT> <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> or other appropriate form; <U>provided</U>, <U>however</U>, that prior to filing
such amendment, the Company shall be obligated to use reasonably diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance
and Disclosure Interpretation&nbsp;612.09. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding any other provision of this Agreement, if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with
the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration
Statement will be reduced as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Second, the Company shall reduce Registrable Securities represented by Securities (applied, in the case that
some Securities may be registered, to the Holders on a pro rata basis based on the total number of unregistered Securities held by such Holders). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In the event of a cutback hereunder, the Company shall give the Holder at least five (5)&nbsp;Trading Days prior written notice along with the
calculations as to such Holder&#146;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its commercially reasonable efforts to file with the Commission, as promptly
as allowed by the Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1,</FONT>
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> is not
available for the registration of the resale of Registrable Securities hereunder, the Company shall (i)&nbsp;register the resale of the Registrable Securities on another appropriate form&nbsp;and (ii)&nbsp;undertake to register the Registrable
Securities on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> as soon as is practicable using commercially reasonable efforts once such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement
then in effect until such time as a Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> covering the Registrable Securities has been declared effective by the Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or
affiliate of a Holder as any underwriter without the prior written consent of such Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Registration Procedures</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Company&#146;s registration obligations hereunder, the Company shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Not less than three (3)&nbsp;Trading Days prior to the filing of each Registration Statement and not less than one
(1)&nbsp;Trading Day prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall (i)&nbsp;furnish to
each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii)&nbsp;cause its officers and directors,
counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act.
The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in writing in good faith, provided that, the
Company is notified of such objection in writing no later than five (5)&nbsp;Trading Days after the Holders have been so furnished copies of a Registration Statement or one (1)&nbsp;Trading Day after the Holders have been so furnished copies of any
related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex</U><U></U><U>&nbsp;C</U> (a &#147;<U>Selling Stockholder
Questionnaire</U>&#148;) on a date that is not less than two (2)&nbsp;Trading Days prior to the Filing Date or by the end of the fourth (4th)&nbsp;Trading Day following the date on which such Holder receives draft materials in accordance with this
Section. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) Prepare and file with the Commission such amendments, including post-effective amendments, to a
Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the
Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii)&nbsp;cause the related Prospectus to be amended or supplemented by any required Prospectus supplement
(subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule&nbsp;424, (iii)&nbsp;respond as promptly as reasonably possible to any comments received from
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence from
and to the Commission relating to a Registration Statement&nbsp;(provided that, the Company shall excise any information contained therein which would constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the
Company or any of its Subsidiaries), and (iv)&nbsp;comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration
Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so
supplemented. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If during the Effectiveness Period, the number of Registrable Securities at any time exceeds&nbsp;100%
of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement covering
the resale by the Holders of not less than the number of such Registrable Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notify the Holders of
Registrable Securities to be sold (which notice shall, pursuant to clauses&nbsp;(iii) through (vi)&nbsp;hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as
reasonably possible (and, in the case of (i)(A)&nbsp;below, not less than one (1)&nbsp;Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1)&nbsp;Trading Day following the day
(i)(A)&nbsp;when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B)&nbsp;when the Commission notifies the Company whether there will be a &#147;review&#148; of such
Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C)&nbsp;with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii)&nbsp;of any
request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii)&nbsp;of the issuance by the Commission or any other federal
or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv)&nbsp;of the receipt by the
Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose,
(v)&nbsp;of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the
Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading, and (vi)&nbsp;of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus;
<U>provided</U>, <U>however</U>, that in no event shall any such notice contain any information which would constitute material, <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any of its Subsidiaries, and the
Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information (in each case,
other than to the extent any Holder is receiving such information in any other capacity that is entitled to receive such information), provided that the Holders shall remain subject to applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Use its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i)&nbsp;any
order stopping or suspending the effectiveness of a Registration Statement, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest
practicable moment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If requested by such Holder, furnish to each Holder, without charge, at least one conformed copy
of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to
the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Subject to the terms of this Agreement, the Company hereby
consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto,
except after the giving of any notice pursuant to Section&nbsp;3(d). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Prior to any resale of Registrable Securities by
a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities
for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not be
required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in
any such jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) If requested by a Holder, cooperate with such Holder to facilitate the
timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all
restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Upon the occurrence of any event contemplated by Section&nbsp;3(d), as promptly as reasonably possible under the
circumstances taking into account the Company&#146;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective
amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a
Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. If the Company notifies the Holders in accordance with clauses&nbsp;(iii) through (vi)&nbsp;of Section&nbsp;3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made,
then the Holders shall suspend use of such Prospectus. The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its
right under this Section&nbsp;3(j) to suspend the availability of a Registration Statement and Prospectus for a period not to exceed&nbsp;60 calendar days (which need not be consecutive days) in
<FONT STYLE="white-space:nowrap">any&nbsp;12-month</FONT> period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Otherwise use commercially reasonable efforts to
comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act, including, without limitation, Rule&nbsp;172 under the Securities Act, file any final Prospectus, including any supplement or amendment
thereof, with the Commission pursuant to Rule&nbsp;424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule&nbsp;172 and, as a
result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities
hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) The Company shall use its commercially reasonable efforts to maintain eligibility for use of <FONT
STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> or <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or any successor form thereto) for the registration of the resale of Registrable Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of
Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Registration Expenses</U>. All fees and expenses incident to the performance of or
compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without
limitation, (i)&nbsp;all registration and filing fees (including, without limitation, fees and expenses of the Company&#146;s counsel and independent registered public accountants) (A)&nbsp;with respect to filings made with the Commission,
(B)&nbsp;with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C)&nbsp;in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in
writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii)&nbsp;printing expenses (including, without limitation, expenses
of printing certificates for Registrable Securities), (iii)&nbsp;messenger, telephone and delivery expenses, (iv)&nbsp;fees and disbursements of counsel for the Company, (v)&nbsp;Securities Act liability insurance, if the Company so desires such
insurance, and (vi)&nbsp;fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal
expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of
any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of
any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>Indemnification</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of
this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a
margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person who
controls any such Holder (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a
functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims,
damages, liabilities, costs (including, without limitation, actual, reasonable and documented attorneys&#146; fees of one counsel) and expenses (collectively, &#147;<U>Losses</U>&#148;), as incurred, arising out of or relating to (1)&nbsp;any untrue
or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or
(2)&nbsp;any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except
to the extent, but only to the extent, that (i)&nbsp;such untrue statements or omissions are based solely </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such
Holder&#146;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it
being understood that the Holder has approved the forms of <U>Annex</U><U></U><U>&nbsp;A and Annex</U><U></U><U>&nbsp;B</U> hereto for this purpose) or (ii)&nbsp;in the case of an occurrence of an event of the type specified in
Section&nbsp;3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by
such Holder and prior to the receipt by such Holder of the Advice contemplated in Section&nbsp;6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the
transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any
Registrable Securities by any of the Holders in accordance with Section&nbsp;6(f). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification by Holders</U>.
Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section&nbsp;15 of the Securities Act and
Section&nbsp;20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based
solely upon: any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
(i)&nbsp;to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or
(ii)&nbsp;to the extent, but only to the extent, that such information relates to such Holder&#146;s information provided in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and
expressly approved in writing by such Holder expressly for use in a Registration Statement&nbsp;(it being understood that the Holder has approved the forms of <U>Annex</U><U></U><U>&nbsp;A and Annex</U><U></U><U>&nbsp;B</U> hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section&nbsp;5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration
Statement giving rise to such indemnification obligation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall
be brought or asserted against any Person entitled to indemnity hereunder (an &#147;<U>Indemnified Party</U>&#148;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &#147;<U>Indemnifying Party</U>&#148;) in
writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense
thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally
determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1)&nbsp;the Indemnifying Party has agreed in writing to pay such fees and expenses, (2)&nbsp;the Indemnifying Party shall have
failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3)&nbsp;the named parties to any such Proceeding (including any impleaded parties) include
both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the
Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the
defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its
written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any
Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees
and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written
notice thereof to the Indemnifying Party, provided that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally
determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U>. If the indemnification under Section&nbsp;5(a) or&nbsp;5(b) is unavailable to an Indemnified Party or
insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The
relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged
omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or
prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#146; or other fees or expenses
of one counsel incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with
its terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties hereto agree that it would not be just and equitable if contribution pursuant to this
Section&nbsp;5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. In no event shall the contribution
obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section&nbsp;5 and the amount of any damages such
Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this
Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under
this Agreement. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that,
in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of
its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements,
other than a Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8,</FONT> until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this
Section&nbsp;6(b) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new securities are registered on any such existing registration statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Discontinued Disposition</U>. By its acquisition of Registrable
Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section&nbsp;3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable
Securities under a Registration Statement until it is advised in writing (the &#147;<U>Advice</U>&#148;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its
commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the
same shall be in writing and signed by the Company and the Holders of&nbsp;50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon conversion of any
Registrable Security), provided that, if any amendment, modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall be required.
If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be
reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the
provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the
Registrable Securities to which such waiver or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of
this Section&nbsp;6(d). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided
hereunder shall be delivered as set forth in the Purchase Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Successors and Assigns</U>. This Agreement
shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without
the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section&nbsp;5.7 of the Purchase Agreement.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>No Inconsistent Agreements</U>. Neither the Company nor any of its
Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights
granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as disclosed in the SEC Reports, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration
rights with respect to any of its securities to any Person that have not been satisfied in full. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Execution and
Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by <FONT STYLE="white-space:nowrap">e-mail</FONT> delivery of a &#147;.pdf&#148; format data file or any
electronic signature complying with the U.S.&nbsp;federal ESIGN Act of&nbsp;2000 (e.g., www.docusign.com), such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the
same force and effect as if such &#147;.pdf&#148; signature page were an original thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Governing Law</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by
law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of
competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated,
and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby
stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of
the Agreement and shall not be deemed to limit or affect any of the provisions hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Independent Nature of
Holders&#146; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of
any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such
obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such
obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional
party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the
convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the
Company and the Holders collectively and not between and among Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******************** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Pages Follow) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ALPHA TEKNOVA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Stephen Gunstream</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE OF HOLDERS FOLLOWS] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[SIGNATURE PAGE OF HOLDERS TO REGISTRATION RIGHTS AGREEMENT] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name of Holder: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Signature of Authorized Signatory of Holder</I>: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name of Authorized Signatory: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title of Authorized Signatory: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGES CONTINUE] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex&nbsp;A </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Plan of Distribution </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each selling stockholder (the &#147;<U>Selling Stockholders</U>&#148;) of the securities and any of their pledgees, assignees and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or
trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker dealer will attempt to sell the securities as agent but may position and resell
a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker dealer as principal and resale by the broker dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions through broker dealers that agree with the Selling Stockholders to sell a specified number of
such securities at a stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may also sell securities under Rule&nbsp;144 or any other exemption from registration under the Securities Act
of&nbsp;1933, as amended (the &#147;<U>Securities Act</U>&#148;), if available, rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker dealers engaged
by the Selling Stockholders may arrange for other brokers dealers to participate in sales. Broker dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule&nbsp;2121; and in the
case of a principal transaction a markup or markdown in compliance with FINRA Rule&nbsp;2121. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of the securities or interests therein, the Selling Stockholders
may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities
short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act in connection with such sales. In such event, any commissions
received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it
does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities,
including liabilities under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We agreed to keep this prospectus effective until the earlier of (i)&nbsp;the date on
which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> limitations by reason of
Rule&nbsp;144, without the requirement for the Company to be in compliance with the current public information under Rule&nbsp;144 under the Securities Act or any other rule of similar effect or (ii)&nbsp;all of the securities have been sold
pursuant to this prospectus or Rule&nbsp;144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws.
In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and
is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale
securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation&nbsp;M, prior to the commencement of the distribution. In addition, the Selling
Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation&nbsp;M, which may limit the timing of purchases and sales of the common stock by the Selling Stockholders or any
other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with
Rule&nbsp;172 under the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex&nbsp;B </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELLING STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
common stock being offered by the Selling Stockholders are those previously issued to the Selling Stockholders. For additional information regarding the issuances of those shares of common stock, see &#147;[Private Placement of Shares of Common
Stock]&#148; [above]. We are registering the shares of common stock in order to permit the Selling Stockholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock, the Selling Stockholders have
not had any material relationship with us within the past three years, other than Telegraph Hill Partners Management Company LLC, through its affiliates Telegraph Hill Partners IV, L.P. and THP IV Affiliates Fund, LLC, our controlling stockholder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below lists the Selling Stockholders and other information regarding the beneficial ownership of the shares of common stock by
each of the Selling Stockholders. The second column lists the number of shares of common stock beneficially owned by each Selling Stockholder, based on its ownership of the shares of common stock, as of ________, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third column lists the shares of common stock being offered by this prospectus by the Selling Stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of a registration rights agreement with the Selling Stockholders, this prospectus generally covers the resale of
the number of shares of common stock issued to the Selling Stockholders in the &#147;[Private Placement of Shares of Common Stock]&#148; described above. The fourth column assumes the sale of all of the shares offered by the Selling Stockholders
pursuant to this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may sell all, some or none of their shares in this offering. See &#147;Plan of
Distribution&#148; for additional information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;shares&nbsp;of<BR>Common&nbsp;Stock&nbsp;Owned<BR>Prior to Offering</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum&nbsp;Number&nbsp;of<BR>shares&nbsp;of&nbsp;Common&nbsp;Stock<BR>to&nbsp;be&nbsp;Sold&nbsp;Pursuant&nbsp;to&nbsp;this<BR>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;shares&nbsp;of<BR>Common&nbsp;Stock&nbsp;Owned<BR>After Offering</B></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex&nbsp;C </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALPHA TEKNOVA, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Selling Stockholder Notice and Questionnaire </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned beneficial owner of common stock (the &#147;<U>Registrable Securities</U>&#148;) of Alpha Teknova, Inc., a Delaware
corporation (the &#147;<U>Company</U>&#148;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) a registration statement&nbsp;(the &#147;<U>Registration
Statement</U>&#148;) for the registration and resale under Rule&nbsp;415 of the Securities Act of&nbsp;1933, as amended (the &#147;<U>Securities Act</U>&#148;), of the Registrable Securities, in accordance with the terms of the Registration Rights
Agreement (the &#147;<U>Registration Rights Agreement</U>&#148;) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not
otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain legal consequences arise
from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the
consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
beneficial owner (the &#147;<U>Selling Stockholder</U>&#148;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby provides the following information to the Company and represents and warrants that
such information is accurate: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONNAIRE </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Name. </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Full Legal Name of Selling Stockholder</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Full Legal Name of Registered Holder (if not the same as (a)&nbsp;above) through which Registrable Securities are held:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Address for Notices to Selling Stockholder: </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-Mail:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Contact&nbsp;Person:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Broker-Dealer Status: </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Are you a broker-dealer? </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8195;&#8195;&#9744;&#8195;&#8195;No&#8195;&#8195;&#9744; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If &#147;yes&#148; to Section&nbsp;3(a), did you receive your Registrable Securities as compensation for
investment banking services to the Company? </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8195;&#8195;&#9744;&#8195;&#8195;No&#8195;&#8195;&#9744; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Note:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If &#147;no&#148; to Section&nbsp;3(b), the Commission&#146;s staff has indicated that you should be identified
as an underwriter in the Registration Statement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Are you an affiliate of a broker-dealer? </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8195;&#8195;&#9744;&#8195;&#8195;No&#8195;&#8195;&#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the
ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8195;&#8195;&#9744;&#8195;&#8195;No&#8195;&#8195;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Note: If &#147;no&#148; to Section&nbsp;3(d), the Commission&#146;s staff has indicated that you should be identified as an underwriter in the
Registration Statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below in this Item&nbsp;4, the undersigned is not the beneficial or registered owner of any
securities of the Company other than the securities issuable pursuant to the Purchase Agreement. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Type and Amount of other securities beneficially owned by the Selling Stockholder:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Relationships with the Company: </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners
of&nbsp;5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">State any exceptions here:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Plan of Distribution and Selling Stockholders: </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The undersigned has reviewed the form of Plan of Distribution and form of Selling Stockholders section attached as Annex&nbsp;A and
Annex&nbsp;B, respectively, to the Registration Rights Agreement, and hereby confirms that, except as set forth below, the information contained therein regarding the undersigned and its plan of distribution is correct and complete. </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">State any exceptions here:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the
information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of
securities held or owned by the undersigned or its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing below, the undersigned consents to the disclosure of the
information contained herein in its answers to Items&nbsp;1 through&nbsp;6 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that
such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with the
provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation&nbsp;M in connection with any offering of Registrable Securities pursuant to the Registration Statement. The undersigned also acknowledges that it
understands that the answers to this Notice and Questionnaire are furnished for use in connection with registration statements filed pursuant to the Registration Rights Agreement and any amendments or supplements thereto filed with the SEC pursuant
to the Securities Act. The undersigned confirms that, to the best of his/her knowledge and belief, the foregoing answers to this Notice and Questionnaire are correct. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and
Questionnaire to be executed and delivered either in person or by its duly authorized agent. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:&nbsp;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Beneficial Owner:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO: </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>d542885dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>LIMITED WAIVER AND AMENDMENT NO.&nbsp;4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this &#147;<B>Agreement</B>&#148;)
is made as of September&nbsp;19, 2023, by and among <B>ALPHA TEKNOVA, INC.</B>, a Delaware corporation (&#147;<B>Borrower</B>&#148;), <B>MIDCAP FINANCIAL TRUST</B>, a Delaware statutory trust, as Agent (in such capacity, together with its successors
and assigns, &#147;<B>Agent</B>&#148;) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Agent,
Lenders and Borrower have entered into that certain Amended and Restated Credit and Security Agreement (Term Loan), dated as of May&nbsp;10, 2022 (as amended by that certain Amendment No.&nbsp;1 to Amended and Restated Credit and Security Agreement
(Term Loan), dated as of November&nbsp;8, 2022 and that certain Amendment No.&nbsp;2 to Amended and Restated Credit and Security Agreement (Term Loan), dated as of March&nbsp;28, 2023, and that certain Amendment No.&nbsp;3 to Amended and Restated
Credit and Security Agreement (Term Loan), dated as of July&nbsp;13, 2023, and as further amended, restated, supplemented or otherwise modified prior to the date hereof, the &#147;<B>Existing A&amp;R Credit Agreement</B>&#148; and as the same is
amended hereby and as it may be further amended, restated, supplemented and modified from time to time, the &#147;<B>Credit Agreement</B>&#148;), pursuant to which the Lenders have agreed to make certain advances of money and to extend certain
financial accommodations to Borrower in the amounts and manner set forth in the Credit Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Borrower has informed Agent that
Borrower&#146;s consolidated Net Revenue for the Defined Period ending July&nbsp;31, 2023 was less than the Minimum Net Revenue Threshold applicable for such Defined Period in violation of Section&nbsp;6.1 of the Credit Agreement, which failure
constitutes an Event of Default under Section&nbsp;10.1(a) of the Credit Agreement (the &#147;<B>Subject Event of Default</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C.
Borrower has requested, and Agent and Lenders have agreed, to (i)&nbsp;waive the Subject Event of Default, (ii)&nbsp;amend certain provisions of the Existing A&amp;R Credit Agreement, and (iii)&nbsp;provide for a prepayment of the Term Loans in
consideration for the agreement of Agent and Lenders herein, in each case, in accordance with the terms and subject to the conditions set forth herein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and Borrower hereby agree as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Defined Terms; Recitals</U></B>. This Agreement shall constitute a Financing Document and the Recitals and each
reference to the Credit Agreement, unless otherwise expressly noted, will be deemed to reference the Credit Agreement as amended hereby. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Credit
Agreement (including those capitalized terms used in the Recitals hereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Limited Waiver</U></B>. Subject to the satisfaction
of the conditions set forth in <U>Section</U><U></U><U>&nbsp;5</U> below, and in reliance on the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;4</U> below, Agent and the Lenders hereby waive the Subject Event of Default.
The limited waiver set forth in this <U>Section</U><U></U><U>&nbsp;2</U> is effective solely for the purposes set forth herein and shall be limited precisely as written and shall not, except as expressly provided herein, be deemed to (a)&nbsp;be a
consent to any amendment, waiver or modification of any term or condition of the Credit Agreement or of any other Financing Document; (b)&nbsp;prejudice any right that Agent </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or Lenders have or may have in the future under or in connection with the Credit Agreement or any other Financing Document; (c)&nbsp;constitute a consent to or waiver of any past, present or
future Default or Event of Default (other than the Subject Event of Default) or other violation of any provisions of the Credit Agreement or any other Financing Documents; (d)&nbsp;create any obligation to forbear from taking any enforcement action,
or to make any further extensions of credit; or (e)&nbsp;establish a custom or course of dealing among any of the Credit Parties, on the one hand, or Agent or any Lender, on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Amendment to Existing A&amp;R Credit Agreement</U></B>. Subject to the terms and conditions of this Agreement, including, without
limitation, the conditions to effectiveness set forth in <U>Section</U><U></U><U>&nbsp;5</U> below, each of the parties hereto agrees to amend the Existing A&amp;R Credit Agreement as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section 1.1 of the Existing A&amp;R Credit Agreement is hereby amended by adding the following definitions in the appropriate alphabetical
order therein: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Fourth Amendment</B>&#148; means that certain Limited Waiver and Amendment No.&nbsp;4 to
Amended and Restated Credit and Security Agreement (Term Loan), dated as of the Second Amendment Effective Date, by and among Borrower, Agent and the Lenders party thereto.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Fourth Amendment Effective Date</B>&#148; means September<U></U> <U></U><U></U>19, 2023.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The definition of &#147;Minimum Net Revenue Threshold&#148; in Section&nbsp;1.1 of the Existing A&amp;R Credit Agreement is hereby amended
and restated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Minimum Net Revenue Threshold</B>&#148; means (a)&nbsp;for each applicable Defined Period ending
on or before December&nbsp;31, 2025, the minimum Net Revenue amount set forth on <U>Schedule 6.1</U> attached hereto for such Defined Period, and (b)&nbsp;for each applicable Defined Period ending after December&nbsp;31, 2025, a minimum Net Revenue
amount determined by Agent in its reasonable discretion in consultation with Borrower Representative&#146;s senior management and based on financial statements and projections delivered to Agent in accordance with Section&nbsp;4.1, which amounts
shall be notified to Borrower Representative by Agent in writing on or prior to December 31<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> of the year ending prior to the year in which such Defined Period ends; <I>provided </I>that in no
event shall the minimum Net Revenue amount for any applicable Defined Period ending after December&nbsp;31, 2025 be less than an amount equal to the greater of (x)&nbsp;the applicable Minimum Net Revenue Threshold amount for the Defined Period
ending on the last day of the immediately preceding month and (y) $50,000,000.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section 2.2(h) of the Existing A&amp;R Credit
Agreement is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;(h) <U>Prepayment Fee</U>. If any advance under the Term Loan
is prepaid at any time, in whole or in part, for any reason<B> </B>(whether by voluntary or mandatory prepayment by Borrower, by reason of the occurrence of an Event of Default or otherwise, or if the Term Loan shall become accelerated (including
any automatic acceleration due to the occurrence of an Event of Default described in Section&nbsp;10.1(f)) or otherwise) and due and payable in full, Borrowers shall pay to Agent, for the benefit of all Lenders committed to make Term Loan advances,
as compensation for the costs of such Lenders making funds available to Borrowers under this Agreement, a prepayment fee (the &#147;<B>Prepayment Fee</B>&#148;) calculated in accordance with this subsection. The Prepayment Fee shall be equal to an
amount </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
determined by <I>multiplying</I> the amount being prepaid (or required to be prepaid, if such amount is greater) <I>by</I> the following applicable percentage amount: (x)&nbsp;four percent
(4.00%) for the first year following the Fourth Amendment Effective Date, (y)&nbsp;three percent (3.00%) for the second year following the Fourth Amendment Effective Date, and (z)&nbsp;two percent (2.00%) thereafter. The Prepayment Fee shall not
apply to or be assessed upon any prepayment made by Borrowers if such payments were (x)&nbsp;required by Agent to be made pursuant to Section&nbsp;2.1(a)(ii)(B) subpart (i) (relating to casualty proceeds), or subpart (ii) (relating to payments
exceeding the Maximum Lawful Rate), (y) required to be made pursuant to Section&nbsp;6(a) of the Fourth Amendment, or (z)&nbsp;made due to the Term Loans being paid in full as a result of a refinancing of the Term Loans in full prior to the Maturity
Date by Agent or an Affiliate of Agent. All fees payable pursuant to this paragraph shall be deemed fully-earned and <FONT STYLE="white-space:nowrap">non-refundable</FONT> as of the Closing Date.<B>&#148;</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Section 6.2 of the Existing A&amp;R Credit Agreement is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;6.2 <U>Minimum Cash</U>. (a)&nbsp;Commencing on the Fourth Amendment Effective Date and continuing at all times thereafter,
Borrowers shall not permit Borrower Unrestricted Cash, at any time to be less than Nine Million Dollars ($9,000,000).&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Schedule
6.1 of the Existing A&amp;R Credit Agreement is hereby deleted and replaced with the Schedule 6.1 attached hereto as Exhibit A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.
<B><U>Representations and Warranties; Reaffirmation of Security Interest</U></B><B>.</B> Each Borrower hereby confirms that all of the representations and warranties set forth in the Credit Agreement are true and correct in all material respects
(without duplication of any materiality qualifier in the text of such representation or warranty) with respect to such Borrower as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which
case such representation or warranty shall be true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of such earlier date. Without limiting the foregoing, each
Borrower represents and warrants that, as of the date hereof, both immediately prior to and immediately after giving effect to this Agreement, no Event of Default, or to such Borrower&#146;s knowledge, Default, has occurred and is continuing.
Nothing herein is intended to impair or limit the validity, priority or extent of Agent&#146;s security interests in and Liens on the Collateral. Each Borrower acknowledges and agrees that each of this Agreement, the Credit Agreement and the other
Financing Documents to which it is a party constitutes the valid and binding agreement or instrument of such Borrower, enforceable against such Borrower in accordance with its respective terms, except as the enforceability thereof may be limited by
bankruptcy, insolvency or other similar laws relating to the enforcement of creditors&#146; rights generally and by general equitable principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><U>Conditions to Effectiveness</U></B><B>. </B>This Agreement shall become effective as of the date on which each of the following
conditions has been satisfied (or waived in writing by the Agent and the Lenders), as determined by Agent in its sole discretion: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Borrower and Lenders shall each have delivered to Agent this Agreement, executed by an authorized officer of each such Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Agent
shall have received a duly executed copy of the Limited Waiver and Amendment No.&nbsp;4 to Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of the date hereof, in respect of the Affiliated Credit Agreement; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Agent shall have received a duly executed copy of the fourth amended and restated Fee
Letter, dated as of the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Agent shall have received the prepayment of the Term Loans as set forth in Section&nbsp;6(a)
below; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) all representations and warranties of Borrowers contained herein shall be true and correct in all material respects (without
duplication of any materiality qualifier in the text of such representation or warranty) as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty
shall be true and correct in all material respects (or, in the case of any representation or warranty that is, by its terms, qualified by materiality, in all respects) as of such earlier date (and such parties&#146; delivery of their respective
signatures hereto shall be deemed to be its certification thereof); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) after giving effect to the agreements set forth herein, no
Default or Event of Default shall exist under any of the Financing Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>Costs and Fees</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On or prior to the date hereof, Borrower shall, in consideration for the waivers and agreements of Agent and Lenders herein, prepay the
principal amount of the Term Loans in an aggregate principal amount equal to $10,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Borrowers shall be responsible for the
payment of all reasonable, documented and invoiced <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and fees of Agent&#146;s counsel incurred in connection with the preparation, negotiation,
execution and delivery of this Agreement and any related Financing Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Release</U></B>. In consideration of the
agreements of Agent and Lenders contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express
intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of its respective current and former directors, officers, shareholders, agents, and
employees, and each of its respective predecessors, successors, heirs, and assigns (individually and collectively, the &#147;<B>Releasing Parties</B>&#148;) does hereby fully and completely release, acquit and forever discharge each of Agent,
Lenders, and each their respective parents, subsidiaries, affiliates, members, managers, shareholders, directors, officers and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the
&#147;Released Parties&#148;), of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or
unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly), based in whole or in part
on facts, whether or not now known, existing on or before the date hereof, that relate to, arise out of or otherwise are in connection with: (i)&nbsp;any or all of the Financing Documents or transactions contemplated thereby or any actions or
omissions in connection therewith or (ii)&nbsp;any aspect of the dealings or relationships between or among any Borrower, on the one hand, and any or all of the Released Parties, on the other hand, relating to any or all of the documents,
transactions, actions or omissions referenced in clause (i)&nbsp;hereof, in each case, based in whole or in part on facts, whether or not now known, existing before the date hereof. Borrower acknowledges that the foregoing release is a material
inducement to Agent&#146;s and each Lender&#146;s decision to enter into this Agreement and agree to the modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection therewith. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>No Waiver or Novation</U></B><B>.</B> The execution, delivery and effectiveness of
this Agreement shall not operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered
in connection with any of the foregoing. Except as expressly set forth in Section&nbsp;2 hereof, nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events of Default under the Credit Agreement or the other
Financing Documents or any of Agent&#146;s rights and remedies in respect of such Defaults or Events of Default. This Agreement (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a
novation of the Credit Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>Affirmation</U></B><B>.</B> Except as specifically amended pursuant to the terms hereof, each
Borrower hereby acknowledges and agrees that the Existing A&amp;R Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and
confirmed in all respects by such Borrower. Each Borrower covenants and agrees to comply with all of the terms, covenants and conditions of the Existing A&amp;R Credit Agreement and the other Financing Documents, notwithstanding any prior course of
conduct, waivers, releases or other actions or inactions on Agent&#146;s or any Lender&#146;s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B><U>Miscellaneous</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reference to the Effect on the Credit Agreement</U>. Upon the effectiveness of this Agreement, (i)&nbsp;this Agreement shall constitute
a &#147;Financing Document&#148; under and as defined in the Credit Agreement and the other Financing Documents and (ii)&nbsp;each reference in the Credit Agreement to &#147;this Agreement,&#148; &#147;hereunder,&#148; &#147;hereof,&#148;
&#147;herein,&#148; or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Incorporation of Credit Agreement Provisions</U>. The provisions contained in <U>Section</U><U></U><U>&nbsp;11.6</U> (<I>Indemnification</I>), <U>Section</U><U></U><U>&nbsp;12.7</U> (<I>Waiver of Consequential and Other Damages</I>),
<U>Section</U><U></U><U>&nbsp;12.8</U> (<I>Governing Law; Submission to Jurisdiction</I>) and <U>Section</U><U></U><U>&nbsp;12.9</U> (<I>Waiver of Jury Trial</I>) of the Credit Agreement are incorporated herein by reference to the same extent as if
reproduced herein in their entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>GOVERNING LAW</U>. THIS AGREEMENT AND ALL DISPUTES AND OTHER MATTERS RELATING HERETO OR
THERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES
(OTHER THAN SECTION <FONT STYLE="white-space:nowrap">5-1401</FONT> OF THE GENERAL OBLIGATIONS LAW). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SUBMISSION TO
JURISDICTION</U>. BORROWER HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN THE STATE OF NEW YORK IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, AND IRREVOCABLY AGREES THAT ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR
RELATING TO THIS AGREEMENT OR THE OTHER FINANCING DOCUMENTS SHALL BE LITIGATED IN SUCH COURTS. BORROWER EXPRESSLY SUBMITS AND CONSENTS TO THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. BORROWER HEREBY WAIVES
PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON BORROWER BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO BORROWER AT THE ADDRESS SET FORTH IN SECTION 12.3 OF THE CREDIT
AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN (10)&nbsp;DAYS AFTER THE SAME HAS BEEN POSTED. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>WAIVER OF JURY TRIAL</U>. BORROWER, AGENT AND THE LENDERS HEREBY IRREVOCABLY WAIVES
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A
JURY. BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT, AND THAT EACH WILL CONTINUE TO RELY ON THIS
WAIVER IN THEIR RELATED FUTURE DEALINGS. BORROWER, AGENT AND EACH LENDER WARRANTS AND REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Headings</U>. Section headings in this Agreement are included for convenience of reference only and shall not constitute a part of
this Agreement for any other purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U>. This Agreement may be signed in any number of counterparts, each of which
shall be deemed an original and all of which when taken together shall constitute one and the same instrument. Delivery of an executed counterpart of this Agreement by facsimile or by electronic mail delivery of an electronic version (e.g., .pdf or
..tif file) of an executed signature page&nbsp;shall be effective as delivery of an original executed counterpart hereof and shall bind the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Entire Agreement</U>. This Agreement constitutes the entire agreement and understanding among the parties hereto and supersedes any and
all prior agreements and understandings, oral or written, relating to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Severability</U>. In case any
provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in
any other jurisdiction, shall not in any way be affected or impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Successors/Assigns</U>. This Agreement shall bind,
and the rights hereunder shall inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit Agreement and the other Financing Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURES APPEAR ON FOLLOWING PAGES] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, intending to be legally bound, the undersigned have executed this
Agreement as of the day and year first hereinabove set forth. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>AGENT:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIDCAP FINANCIAL TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management, L.P.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">its investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management GP, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: /s/ Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LENDERS:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIDCAP FINANCIAL TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management, L.P.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management GP, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: /s/ Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LENDERS:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIDCAP FUNDING XIII TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management, L.P.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management GP, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: /s/ Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LENDERS:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ELM <FONT STYLE="white-space:nowrap">2020-3</FONT> TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: MidCap Financial Services Capital Management, LLC, as Servicer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: /s/ John O&#146;Dea</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: John O&#146;Dea</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ELM <FONT STYLE="white-space:nowrap">2020-4</FONT> TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: MidCap Financial Services Capital Management, LLC, as Servicer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: /s/ John O&#146;Dea</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: John O&#146;Dea</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BORROWER:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ALPHA TEKNOVA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: /s/ Matthew Lowell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Matthew Lowell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: CFO</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule&nbsp;6.1 &#150; Minimum Net Revenue Schedule </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Defined Period Ending</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Minimum&nbsp;Net&nbsp;Revenue<BR>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$34,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$34,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$35,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$36,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$39,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$35,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$35,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$35,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$36,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$36,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;29, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$37,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$39,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$40,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$41,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$42,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$43,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$44,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$44,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$45,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$46,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$46,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$47,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$48,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$48,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$49,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>7
<FILENAME>d542885dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>LIMITED WAIVER AND AMENDMENT NO.&nbsp;4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this
&#147;<B>Agreement</B>&#148;) is made as of September&nbsp;19, 2023, by and among <B>ALPHA TEKNOVA, INC.</B>, a Delaware corporation (&#147;<B>Borrower</B>&#148;), <B>MIDCAP FUNDING IV TRUST</B>, a Delaware statutory trust, as Agent (in such
capacity, together with its successors and assigns, &#147;<B>Agent</B>&#148;) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Agent,
Lenders and Borrower have entered into that certain Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of May&nbsp;10, 2022 (as amended by that certain Amendment No.&nbsp;1 to Amended and Restated Credit and Security
Agreement (Revolving Loan), dated as of November&nbsp;8, 2022, that certain Amendment No.&nbsp;2 to Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of March&nbsp;28, 2023, and that certain Amendment No.&nbsp;3 to
Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of July&nbsp;13, 2023, and as further amended, restated, supplemented or otherwise modified prior to the date hereof, the &#147;<B>Existing A&amp;R Credit
Agreement</B>&#148; and as the same is amended hereby and as it may be further amended, restated, supplemented and modified from time to time, the &#147;<B>Credit Agreement</B>&#148;), pursuant to which the Lenders have agreed to make certain
advances of money and to extend certain financial accommodations to Borrower in the amounts and manner set forth in the Credit Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Borrower has informed Agent that Borrower&#146;s consolidated Net Revenue for the Defined Period ending July&nbsp;31, 2023 was less than
the Minimum Net Revenue Threshold applicable for such Defined Period in violation of Section&nbsp;6.1 of the Credit Agreement, which failure constitutes an Event of Default under Section&nbsp;10.1(a) of the Credit Agreement (the &#147;<B>Subject
Event of Default</B>&#148;). <B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Borrower has requested, and Agent and Lenders have agreed, to (i)&nbsp;waive the Subject Event of
Default and (ii)&nbsp;amend certain provisions of the Existing A&amp;R Credit Agreement, in each case, in accordance with the terms and subject to the conditions set forth herein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and Borrower hereby agree as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Defined Terms; Recitals</U></B>. This Agreement shall constitute a Financing Document and the Recitals and each
reference to the Credit Agreement, unless otherwise expressly noted, will be deemed to reference the Credit Agreement as amended hereby. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Credit
Agreement (including those capitalized terms used in the Recitals hereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Limited Waiver</U></B>. Subject to the satisfaction
of the conditions set forth in <U>Section</U><U></U><U>&nbsp;5</U> below, and in reliance on the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;4</U> below, Agent and the Lenders hereby waive the Subject Event of Default.
The limited waiver set forth in this <U>Section</U><U></U><U>&nbsp;2</U> is effective solely for the purposes set forth herein and shall be limited precisely as written and shall not, except as expressly provided herein, be deemed to (a)&nbsp;be a
consent to any amendment, waiver or modification of any term or condition of the Credit Agreement or of any other Financing Document; (b)&nbsp;prejudice any right that Agent or Lenders have or may have in the future under or in connection with the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Credit Agreement or any other Financing Document; (c)&nbsp;constitute a consent to or waiver of any past, present or future Default or Event of Default (other than the Subject Event of Default)
or other violation of any provisions of the Credit Agreement or any other Financing Documents; (d)&nbsp;create any obligation to forbear from taking any enforcement action, or to make any further extensions of credit; or (e)&nbsp;establish a custom
or course of dealing among any of the Credit Parties, on the one hand, or Agent or any Lender, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Amendment to
Existing A&amp;R Credit Agreement</U></B>. Subject to the terms and conditions of this Agreement, including, without limitation, the conditions to effectiveness set forth in <U>Section</U><U></U><U>&nbsp;5</U> below, each of the parties hereto
agrees to amend the Existing A&amp;R Credit Agreement as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section 1.1 of the Existing A&amp;R Credit Agreement is hereby
amended by adding the following definitions in the appropriate alphabetical order therein: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Fourth
Amendment</B>&#148; means that certain Limited Waiver and Amendment No.&nbsp;4 to Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of the Second Amendment Effective Date, by and among Borrower, Agent and the Lenders
party thereto.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Fourth Amendment Effective Date</B>&#148; means September 19, 2023.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The definition of &#147;Minimum Net Revenue Threshold&#148; in Section&nbsp;1.1 of the Existing A&amp;R Credit Agreement is hereby amended
and restated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B>Minimum Net Revenue Threshold</B>&#148; means (a)&nbsp;for each applicable Defined Period ending
on or before December&nbsp;31, 2025, the minimum Net Revenue amount set forth on <U>Schedule 6.1</U> attached hereto for such Defined Period, and (b)&nbsp;for each applicable Defined Period ending after December&nbsp;31, 2025, a minimum Net Revenue
amount determined by Agent in its reasonable discretion in consultation with Borrower Representative&#146;s senior management and based on financial statements and projections delivered to Agent in accordance with Section&nbsp;4.1, which amounts
shall be notified to Borrower Representative by Agent in writing on or prior to December&nbsp;31<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> of the year ending prior to the year in which such Defined Period ends; <I>provided </I>that in
no event shall the minimum Net Revenue amount for any applicable Defined Period ending after December&nbsp;31, 2025 be less than an amount equal to the greater of (x)&nbsp;the applicable Minimum Net Revenue Threshold amount for the Defined Period
ending on the last day of the immediately preceding month and (y) $50,000,000.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section 2.2(g) of the Existing A&amp;R Credit
Agreement is hereby amended by deleting the phrase &#147;First Amendment Effective Date&#148; where it appears therein and replacing it with the phrase &#147;Fourth Amendment Effective Date&#148;; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Section 6.2 of the Existing A&amp;R Credit Agreement is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;6.2 <U>Minimum Cash</U>. (a)&nbsp;Commencing on the Fourth Amendment Effective Date and continuing at all times thereafter,
Borrowers shall not permit Borrower Unrestricted Cash, at any time to be less than Nine Million Dollars ($9,000,000).&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Section 7.2(d) of the Existing A&amp;R Credit Agreement is hereby amended and restated
in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;(d) for the initial borrowing of Revolving Loans on or after the Fourth Amendment Effective Date,
Borrower shall have delivered after the Fourth Amendment Effective Date but prior to such borrowing of Revolving Loans financial statements required pursuant to Section&nbsp;4.1(a) and the corresponding Compliance Certificate pursuant to
Section&nbsp;4.1(i) demonstrating to Agent&#146;s and each Lender&#146;s satisfaction that Net Revenue for the preceding twelve (12)&nbsp;calendar months (ending on the last day of the calendar month for which such Compliance Certificate is
delivered) is greater than or equal to $45,000,000.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Schedule 6.1 of the Existing A&amp;R Credit Agreement is hereby deleted and
replaced with the Schedule 6.1 attached hereto as Exhibit A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><U>Representations and Warranties; Reaffirmation of Security
Interest</U></B><B>.</B> Each Borrower hereby confirms that all of the representations and warranties set forth in the Credit Agreement are true and correct in all material respects (without duplication of any materiality qualifier in the text of
such representation or warranty) with respect to such Borrower as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct in
all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of such earlier date. Without limiting the foregoing, each Borrower represents and warrants that, as of the date hereof, both
immediately prior to and immediately after giving effect to this Agreement, no Event of Default, or to such Borrower&#146;s knowledge, Default, has occurred and is continuing. Nothing herein is intended to impair or limit the validity, priority or
extent of Agent&#146;s security interests in and Liens on the Collateral. Each Borrower acknowledges and agrees that each of this Agreement, the Credit Agreement and the other Financing Documents to which it is a party constitutes the valid and
binding agreement or instrument of such Borrower, enforceable against such Borrower in accordance with its respective terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the
enforcement of creditors&#146; rights generally and by general equitable principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><U>Conditions to Effectiveness</U></B><B>.
</B>This Agreement shall become effective as of the date on which each of the following conditions has been satisfied (or waived in writing by the Agent and the Lenders), as determined by Agent in its sole discretion: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Borrower and Lenders shall each have delivered to Agent this Agreement, executed by an authorized officer of each such Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Agent shall have received a duly executed copy of the Limited Waiver and Amendment No.&nbsp;4 to Amended and Restated Credit and Security
Agreement (Term Loan), dated as of the date hereof, in respect of the Affiliated Credit Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) all representations and warranties
of Borrowers contained herein shall be true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of the date hereof except to the extent that any such
representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct in all material respects (or, in the case of any representation or warranty that is, by its terms, qualified by
materiality, in all respects) as of such earlier date (and such parties&#146; delivery of their respective signatures hereto shall be deemed to be its certification thereof); and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) after giving effect to the agreements set forth herein, no Default or Event of Default
shall exist under any of the Financing Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>Costs and Fees</U></B>. Borrowers shall be responsible for the payment of all
reasonable, documented and invoiced <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and fees of Agent&#146;s counsel incurred in connection with the preparation, negotiation, execution and delivery
of this Agreement and any related Financing Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Release</U></B>. In consideration of the agreements of Agent and Lenders
contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of
itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of its respective current and former directors, officers, shareholders, agents, and employees, and each of its
respective predecessors, successors, heirs, and assigns (individually and collectively, the &#147;<B>Releasing Parties</B>&#148;) does hereby fully and completely release, acquit and forever discharge each of Agent, Lenders, and each their
respective parents, subsidiaries, affiliates, members, managers, shareholders, directors, officers and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the &#147;Released
Parties&#148;), of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated
or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly), based in whole or in part on facts, whether or
not now known, existing on or before the date hereof, that relate to, arise out of or otherwise are in connection with: (i)&nbsp;any or all of the Financing Documents or transactions contemplated thereby or any actions or omissions in connection
therewith or (ii)&nbsp;any aspect of the dealings or relationships between or among any Borrower, on the one hand, and any or all of the Released Parties, on the other hand, relating to any or all of the documents, transactions, actions or omissions
referenced in clause (i)&nbsp;hereof, in each case, based in whole or in part on facts, whether or not now known, existing before the date hereof. Borrower acknowledges that the foregoing release is a material inducement to Agent&#146;s and each
Lender&#146;s decision to enter into this Agreement and agree to the modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>No Waiver or Novation</U></B><B>.</B> The execution, delivery and effectiveness of this Agreement shall not operate as a waiver of
any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection with any of the foregoing. Except
as expressly set forth in Section&nbsp;2 hereof, nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events of Default under the Credit Agreement or the other Financing Documents or any of Agent&#146;s rights and
remedies in respect of such Defaults or Events of Default. This Agreement (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>Affirmation</U></B><B>.</B> Except as specifically amended pursuant to the terms hereof, each Borrower hereby acknowledges and agrees
that the Existing A&amp;R Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and confirmed in all respects by such Borrower.
Each Borrower covenants and agrees to comply with all of the terms, covenants and conditions of the Existing A&amp;R Credit Agreement and the other Financing Documents, notwithstanding any prior course of conduct, waivers, releases or other actions
or inactions on Agent&#146;s or any Lender&#146;s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B><U>Miscellaneous</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reference to the Effect on the Credit Agreement</U>. Upon the effectiveness of this Agreement, (i)&nbsp;this Agreement shall constitute
a &#147;Financing Document&#148; under and as defined in the Credit Agreement and the other Financing Documents and (ii)&nbsp;each reference in the Credit Agreement to &#147;this Agreement,&#148; &#147;hereunder,&#148; &#147;hereof,&#148;
&#147;herein,&#148; or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Incorporation of Credit Agreement Provisions</U>. The provisions contained in <U>Section</U><U></U><U>&nbsp;11.6</U> (<I>Indemnification</I>), <U>Section</U><U></U><U>&nbsp;12.7</U> (<I>Waiver of Consequential and Other Damages</I>),
<U>Section</U><U></U><U>&nbsp;12.8</U> (<I>Governing Law; Submission to Jurisdiction</I>) and <U>Section</U><U></U><U>&nbsp;12.9</U> (<I>Waiver of Jury Trial</I>) of the Credit Agreement are incorporated herein by reference to the same extent as if
reproduced herein in their entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>GOVERNING LAW</U>. THIS AGREEMENT AND ALL DISPUTES AND OTHER MATTERS RELATING HERETO OR
THERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES
(OTHER THAN SECTION <FONT STYLE="white-space:nowrap">5-1401</FONT> OF THE GENERAL OBLIGATIONS LAW). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SUBMISSION TO
JURISDICTION</U>. BORROWER HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN THE STATE OF NEW YORK IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, AND IRREVOCABLY AGREES THAT ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR
RELATING TO THIS AGREEMENT OR THE OTHER FINANCING DOCUMENTS SHALL BE LITIGATED IN SUCH COURTS. BORROWER EXPRESSLY SUBMITS AND CONSENTS TO THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. BORROWER HEREBY WAIVES
PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON BORROWER BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO BORROWER AT THE ADDRESS SET FORTH IN SECTION 12.3 OF THE CREDIT
AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN (10)&nbsp;DAYS AFTER THE SAME HAS BEEN POSTED. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>WAIVER OF JURY TRIAL</U>.
BORROWER, AGENT AND THE LENDERS HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND AGREES THAT ANY SUCH ACTION OR
PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN ENTERING INTO THIS
AGREEMENT, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. BORROWER, AGENT AND EACH LENDER WARRANTS AND REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT
KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Headings</U>. Section headings in this Agreement are included for
convenience of reference only and shall not constitute a part of this Agreement for any other purpose. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U>. This Agreement may be signed in any number of counterparts, each of
which shall be deemed an original and all of which when taken together shall constitute one and the same instrument. Delivery of an executed counterpart of this Agreement by facsimile or by electronic mail delivery of an electronic version (e.g.,
..pdf or .tif file) of an executed signature page&nbsp;shall be effective as delivery of an original executed counterpart hereof and shall bind the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Entire Agreement</U>. This Agreement constitutes the entire agreement and understanding among the parties hereto and supersedes any and
all prior agreements and understandings, oral or written, relating to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Severability</U>. In case any
provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in
any other jurisdiction, shall not in any way be affected or impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Successors/Assigns</U>. This Agreement shall bind,
and the rights hereunder shall inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit Agreement and the other Financing Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURES APPEAR ON FOLLOWING PAGES] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, intending to be legally bound, the undersigned have executed this
Agreement as of the day and year first hereinabove set forth. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>AGENT:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIDCAP FUNDING IV TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management, L.P.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">its&nbsp;investment&nbsp;manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management GP, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">/s/ Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LENDER:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIDCAP FUNDING IV TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management, L.P.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apollo Capital Management GP, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: /s/ Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Maurice Amsellem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Authorized Signatory</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BORROWER:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ALPHA TEKNOVA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">/s/ Matthew Lowell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Matthew Lowell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: CFO</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule&nbsp;6.1 &#150; Minimum Net Revenue Schedule </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Defined Period Ending</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Minimum&nbsp;Net&nbsp;Revenue<BR>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;29, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>d542885dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOLLISTER, Calif., Sept. 18, 2023</B> &#151; Alpha Teknova, Inc. (&#147;Teknova&#148;) (Nasdaq: TKNO), a leading producer of critical reagents for the
research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of up to 1,086,485 of its shares of common
stock in a registered direct offering at a purchase price of $1.85 per share. In a concurrent private placement, Teknova has also agreed to issue and sell an aggregate of up to 11,299,993 of its shares of common stock, at the same purchase price of
$1.85 per share as in the registered direct offering. The registered direct offering and the private placement were priced based on the consolidated closing bid price under Nasdaq rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offerings are expected to close on or about September&nbsp;19, 2023, subject to the satisfaction of customary closing conditions. The gross proceeds to
Teknova from the concurrent offerings are expected to be up to approximately $22.915&nbsp;million, before deducting offering expenses payable by Teknova. Teknova currently intends to use the net proceeds from the offerings for general corporate
purposes (including for the repayment of a portion of Teknova&#146;s outstanding debt obligations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities offered in the registered direct
offering (but excluding the securities offered in the private placement) are being offered and sold by Teknova pursuant to a &#147;shelf&#148; registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-265987),</FONT> including a base prospectus, previously filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on July&nbsp;1, 2022 and declared effective by the SEC on July&nbsp;12, 2022. The
offering of the securities to be issued in the registered direct offering is being made only by means of a prospectus supplement that forms a part of the registration statement. A final prospectus supplement and an accompanying base prospectus
relating to the registered direct offering will be filed with the SEC and will be available on the SEC&#146;s website located at<U>&nbsp;http://www.sec.gov</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offer and sale of the securities in the private placement described above are being made in transactions not involving a public offering and have not been
registered pursuant to Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and/or Rule 506(b) of Regulation D promulgated thereunder and have not been registered under the Securities Act or applicable
state securities laws. Accordingly, the securities in the private placement may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of
the Securities Act and such applicable state securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teknova has agreed to file an initial registration statement with the SEC covering the
resale of the securities to be issued in the private placement no later than 45 days following the date of the definitive agreement and to use commercially reasonable efforts to have the registration statement declared effective as promptly as
practical thereafter, and in any event no later than 120 days after the date of the definitive agreement in the event of a &#147;full review&#148; by the SEC. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or
jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Teknova </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teknova makes solutions
possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully
customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and
reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> facilities, Teknova&#146;s modular manufacturing platform was designed by our team of scientists, engineers, and
quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this press
release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute &#147;forward-looking statements.&#148; These statements include, but are not limited to,
Teknova&#146;s expectations regarding the completion of the offerings, the satisfaction of customary closing conditions related to the offerings, the timing of filing and effectiveness of any registration statement and the anticipated use of
proceeds from the offerings. The words, without limitation, &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148;
&#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions are intended to identify forward-looking statements, although not all
forward-looking statements contain these or similar identifying words. These forward-looking statements are based on management&#146;s current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to
predict and many of which are beyond Teknova&#146;s control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to,
risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the offerings; demand for Teknova&#146;s products (including the potential delay or pausing of customer orders); Teknova&#146;s
assessment of fundamental indicators of future demand across its target customer base; Teknova&#146;s ability to expand its production, commercial, and research and development capabilities; Teknova&#146;s cash flows and revenue growth rate;
Teknova&#146;s supply chain, sourcing, manufacturing and warehousing; inventory management; risks related to global economic and marketplace uncertainties, including those related to the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic; reliance on a limited number of customers for a high percentage of Teknova&#146;s revenue; potential acquisitions and integration of other companies; and other factors discussed in the &#147;Risk Factors&#148; section of Teknova&#146;s
most recent periodic reports filed with the Securities and Exchange Commission (&#147;SEC&#148;), including in Teknova&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31,
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
2022 and subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC, all of which you may obtain for free on the SEC&#146;s website at www.sec.gov.
Although Teknova believes that the expectations reflected in its forward-looking statements are reasonable, Teknova does not know whether its expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, even if subsequently made available by Teknova on its website or otherwise. Teknova does not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a
result of new information, future events or otherwise, except as may be required under applicable securities laws. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contacts</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matt Lowell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jennifer Henry</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Vice President, Marketing</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">matt.lowell@teknova.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">jenn.henry@teknova.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">831-637-1100</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">831-313-1259</FONT></FONT></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sara Michelmore</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MacDougall Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">smichelmore@macdougall.bio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">+1
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">781-235-3060</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>9
<FILENAME>d542885dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Private Placement and Amends Credit Facility </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOLLISTER, Calif., Sept. 19, 2023</B> &#151; Alpha Teknova, Inc. (&#147;Teknova&#148;) (Nasdaq: TKNO), a leading producer of critical reagents for the
research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the closing of its previously announced registered direct offering for the issuance and sale of an aggregate of 1,086,485 of its
shares of common stock at a purchase price of $1.85 per share and concurrent private placement of an aggregate of 11,299,993 of its shares of common stock, at the same purchase price of $1.85 per share. The registered direct offering and the private
placement were priced based on the consolidated closing bid price under Nasdaq rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The gross proceeds to Teknova from the concurrent offerings are
approximately $22.915&nbsp;million, before deducting offering expenses payable by Teknova. Teknova currently intends to use the net proceeds from the offerings for general corporate purposes, including for the repayment of a portion of
Teknova&#146;s outstanding debt obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities offered in the registered direct offering were offered and sold by Teknova pursuant to a
&#147;shelf&#148; registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-265987),</FONT> including a base prospectus, previously filed with the Securities and Exchange
Commission (the &#147;SEC&#148;) on July&nbsp;1, 2022 and declared effective by the SEC on July&nbsp;12, 2022. The offering of the securities issued in the registered direct offering was made only by means of a prospectus supplement that forms a
part of the registration statement. A final prospectus supplement and an accompanying base prospectus relating to the registered direct offering have been filed with the SEC and are available on the SEC&#146;s website located
at<U>&nbsp;http://www.sec.gov</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offer and sale of the securities in the private placement described above were made in transactions not involving
a public offering and have not been registered pursuant to Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and/or Rule 506(b) of Regulation D promulgated thereunder and have not been registered under
the Securities Act or applicable state securities laws. Accordingly, the securities sold in the private placement may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption
from the registration requirements of the Securities Act and any applicable state securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to
sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment to Credit Facility </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent with the equity offerings, Teknova has completed Amendment No.&nbsp;4 (the &#147;Amendment&#148;) to its Amended Credit Agreement with MidCap
Financial Trust (&#147;MidCap&#148;). The Amendment lowers covenants for minimum net revenue and minimum cash. In return, Teknova agreed to an increase of the exit fee and restricted access to the revolving facility
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
until Teknova achieves a minimum net revenue trigger. Teknova has also repaid $10.0&nbsp;million of principal balance on its term loan to MidCap in connection with the Amendment. This summary of
the Amendment does not purport to be complete. Additional information about the Amendment will be available in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed by Teknova. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ABOUT TEKNOVA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teknova makes solutions possible. Since
1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable
solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water
helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> facilities, Teknova&#146;s modular manufacturing platform was designed by our team of scientists, engineers, and
quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this press
release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute &#147;forward-looking statements.&#148; These statements include, but are not limited to,
Teknova&#146;s expectations regarding the anticipated use of proceeds from the offerings. The words, without limitation, &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148;
&#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain these or similar identifying words. These forward-looking statements are based on management&#146;s current expectations and beliefs and are subject to uncertainties and
factors, all of which are difficult to predict and many of which are beyond Teknova&#146;s control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks and
uncertainties include, but are not limited to, risks and uncertainties associated with market conditions; demand for Teknova&#146;s products (including the potential delay or pausing of customer orders); Teknova&#146;s assessment of fundamental
indicators of future demand across its target customer base; Teknova&#146;s ability to expand its production, commercial, and research and development capabilities; Teknova&#146;s cash flows and revenue growth rate; Teknova&#146;s supply chain,
sourcing, manufacturing and warehousing; inventory management; risks related to global economic and marketplace uncertainties, including those related to the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; reliance on a
limited number of customers for a high percentage of Teknova&#146;s revenue; potential acquisitions and integration of other companies; and other factors discussed in the &#147;Risk Factors&#148; section of Teknova&#146;s most recent periodic
reports filed with the SEC, including in Teknova&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022 and subsequent Quarterly Reports on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC, all of which you may obtain for free on the SEC&#146;s website at www.sec.gov. Although Teknova believes that the expectations reflected in its
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forward-looking statements are reasonable, Teknova does not know whether its expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date hereof, even if subsequently made available by Teknova on its website or otherwise. Teknova does not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required under applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Contacts: Matt Lowell, Chief Financial
Officer, matt.lowell@teknova.com, +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">831-637-1100;</FONT></FONT> Sara Michelmore, MacDougall Advisors, smichelmore@macdougall.bio, +1 <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">781-235-3060;</FONT></FONT> Media Contact: Jennifer Henry, Senior Vice President &#151; Marketing, jenn.henry@teknova.com,+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">831-313-1259</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>tkno-20230915.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/19/2023 11:58:09 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:tkno="http://www.teknova.com/20230915"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.teknova.com/20230915"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tkno-20230915_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tkno-20230915_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>tkno-20230915_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/19/2023 11:58:09 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>tkno-20230915_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/19/2023 11:58:09 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tkno-20230915.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g542885g0919013120158.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542885g0919013120158.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  K ) # 2(  A$! Q$!_\0
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?#[$$&N-\!6<.L:D9M2,MV]J=T/GS.X0CH<$XH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g542885g0919013120364.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542885g0919013120364.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ? <0# 2(  A$! Q$!_\0
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MV%9=[X?5_+%CY<"@GS%P?FR,9R.>*IP>&;N&Q2R^UQF$.DC-L.XE0!CZ' H
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MIKEU)-J "3A+5(6*DL1ND!Z<=ZK_ &JZ69IT=I+ESM6V.X/'\O!]#79%5/4
M_A1A=V[ SZXH YC3+F.&\A:.>1XC!FYWDG$A.!]#56>Z2.[\R.ZG$31R>>02
M9%/NO8>E=CA>>!SUXHVKDG R>IQ0!QL$JNT3M<LNGR2_.@D)*87C<>V3DUKZ
M7,T^E-;F>19"',3G[WEY(4UM;5QC:,'J,4O% '&7;W9T[38WG*G[,Y9YF*AF
M[<C^*H_M-TUG++YDXU0,@MHVSEA@=O3KFNW(4\$ _448&<X&?6@#F]%DS?VP
MAFEDW6Y-T').'R,9]#UK3E:3_A(;906\LV[DCMG(K1 49P ,]:7B@#$UN^U&
MTGBALD5VN%V1$KD*XY.?;%9S:WJTL*2V\(_TLE+960_*R]2WL0#7644 <FVM
MZM+"DMO"/],)2V5D/R,O4M[$9J:37[A?#]U?_+'(06MT=#G:" 21]3FNFJ.:
M&*XB:*9 Z-U4]Z .7FUN[24P1W(DC8@K<", 9VDE>>/3\Z;;>)+J?2\R@+=2
M/$JQA3G:P7<?SW?E76;$"A=HP.V*7"YS@9]<4 <;IUYJ=II_VHR.Z"=$,3(2
M2IC&3^=-7Q#J+2&(3)M98W$A4#KNR >@/ Z^M=IQ2;$V[=HQZ8H X=]5U+?+
M<AWD++"\<31D!?W;DG'^\!6E+J.I6MQ%!/<*(I5C9[CRO]7N#Y'YJ/SKI\#.
M<5%<VL-W&(YDW*#N&"00?J* .2A\17\BQ2&5&02,OR1X,@$S)G!Z_*!TK3O=
M6D^VLL5TL$"Q!HV,>[S7W$%?PP./>MJ"V@MH4BAC543[H]*EPIQD#CD<4 <A
M-KNI):-+$RO<LDI>V\LY@*YVY_' ]\U=:\U2WOG5I1+%'>0P@>5C<C@$G/L3
4^E=%A<DX&3U..M'% "T444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g542885g0919013120492.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542885g0919013120492.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W +@# 2(  A$! Q$!_\0
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M/SKNO%-W!8^%=5GN)%2-;609)[E2 /KFE#X/O'B4WB%;^[^2.;^#W_)-=/\
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M?[.G]CBZ^R&Z_P!O'/ZUZ!7C_P!H\,GX<'1CJ<7]H$?:2V#GS^O7_P =KO?
M^N?V[X8MII&S<0CR9O7<._XC!H G\4^(H_#>E"Z:(S32.(H8A_$QK"%U\0&A
M%R+/3U!&[R"WS8]/K6OXP\/#Q%ID4$=PMO=0RB6!VZ;AVK$6_P#B!IJA9],M
M=05>-\3X8_Y^E &WX4\3CQ#;W"36YMKZT?RYX3V/J/R--URZ\40Z@%T>QMI[
M7RP2\CX.[G(_E4'A/Q%9:S=WL7]G?8-4C(-S$R@,WOGOSZUU5 'G4'BGQA<Z
MS<Z3'IMD;RV0/(N_@ XQS^(KJ_#\^O3_ &C^V[2"WQM\KRGSGKG/Z5S^B_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140501910949056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001850902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALPHA TEKNOVA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3368109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2451 Bert Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hollister<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(831)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">637-1100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TKNO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d542885d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tkno-20230915.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-15_to_2023-09-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001850902</identifier>
        </entity>
        <period>
            <startDate>2023-09-15</startDate>
            <endDate>2023-09-15</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-09-15_to_2023-09-15">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-15_to_2023-09-15"
      id="Hidden_dei_EntityCentralIndexKey">0001850902</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-09-15_to_2023-09-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-15_to_2023-09-15">2023-09-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-09-15_to_2023-09-15">ALPHA TEKNOVA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-15_to_2023-09-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-15_to_2023-09-15">001-40538</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-15_to_2023-09-15">94-3368109</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-15_to_2023-09-15">2451 Bert Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-15_to_2023-09-15">Hollister</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-15_to_2023-09-15">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-15_to_2023-09-15">95023</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-15_to_2023-09-15">(831)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-15_to_2023-09-15">637-1100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-15_to_2023-09-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-15_to_2023-09-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-15_to_2023-09-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-15_to_2023-09-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-15_to_2023-09-15">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-15_to_2023-09-15">TKNO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-15_to_2023-09-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-15_to_2023-09-15">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2023-09-15_to_2023-09-15">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>18
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ ?8,S5Y>*NQS     $P(   L
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( 'V#,U>-_/AU: 0  "01   8
M          " @0\(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !]@S-7GZ ;\+$"  #B#   #0              @ &M#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( 'V#,U>7BKL<P    !,"   +
M  "  8D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( 'V#,U<<.&7J/P$  #P"
M   /              "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !]@S-7)!Z;HJT   #X 0  &@              @ '>$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !]@S-799!YDAD!  #/ P
M$P              @ '#$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"   -%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d542885d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d542885d8k.htm">d542885d8k.htm</File>
    <File>tkno-20230915.xsd</File>
    <File>tkno-20230915_lab.xml</File>
    <File>tkno-20230915_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d542885d8k.htm": {
   "nsprefix": "tkno",
   "nsuri": "http://www.teknova.com/20230915",
   "dts": {
    "inline": {
     "local": [
      "d542885d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "tkno-20230915.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tkno-20230915_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tkno-20230915_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2022": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "report": {
    "R1": {
     "role": "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-09-15_to_2023-09-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d542885d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-09-15_to_2023-09-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d542885d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.teknova.com//20230915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001193125-23-237669-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-237669-xbrl.zip
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M>&H&<N&WF];[-=#K$<D+#ZO&6C#6@[VR/WZZ/D^'1\7CTZ'U**2>&/GAE$;
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M3 C]SSFX6=:CQ;+9[ECD)T M.0GY?8%1>&T_=SL<#.#/R_#6GWF/QL G<+C
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M7/'5>82A[[M#"N2*@+D0R[WW[?;!LBG8% A(V#/D)7F*DJ_6M@N-$*4CC0]
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M=R _NRY[7FR2)VQ6;$0KPR&#RX(&+OPNS\Y@PPHZ&_QG^J$6]8NGI&RG%5@
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M-EM6LQJ%6?J#^&)8;_.B/(-G/]CQ;$D+V;%52PJZ])BZ<58/[W;:[,FS=;U
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M)3Z=2SXPXX /@__FBJY3/Q6CU8RJTUBUP3<4LV:5'B1L(FX=^$=PH G,)Y5
M'8Q$4>Y\<T@X!(/^ C81M.R.382_?MW$SV<3SXZ>@8, 8OC#!H,_JSB_/T!I
M8Q+#8>2W!T$FJBOC X7Z!-$K0S,K/*N!D_[YP$E#0_>FE%V4J7OT_ZM,W=DE
MG/3LK$B@-LB,4=@V?@KMB4XK-WVM$AQW+\T>WK]/@/A3MPABA?WZVI1$!%G0
M/01;;@&SLTU5"N8:;UP]^QN<P$G3M@RQ3!_6S^JV#5&M [B(I/;CHDQ"X5[
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M8[QN8("_:GJ\UACVY>Q7O0$K%_[!@M4EI(EC [S6/*OF0<T<HU6\I\J_G(O
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MZWN9>3^]\X@;%M)B&1#XI6 YKZI:_(_(%\B]13Y #!&W"J8>U.-&2W"**J"
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M4#(%YW2.VV9]P2OVO"3B242FGV/2(J3LD("^#QB!!D.4+T<Q79/W%"&"<GW
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M<\JCK5H.W>@5J+MRX5.,-EZNOI%2VW"_<^[DR:UGR-3VOW2+?0LF863\8.)
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M>[SSX@5>Y3)6"4BH;KCWA6@!@L+6@H5=$NQ"M.'(N2?NOV)ZN,=)$32/XBX
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M?T$4](( ]W0J*IB4-4B0+<5R4EVLI6JN+9U+#_J.7$_38F76%O/>H^""@R'
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MX7C]Q_V[^7=W'^;???O-T=U'(4[X*#L)'7!VI%SE:A->F2NX#D'I=[[-X&9
M@ MNQ![#_EZRR-:N6-J=$*WE])'":-T+CKCP7)9X,*4HYH!J$6[^2E#RMG05
MO53<8W)4MY1JWS\H#OW6;>%"DK"SK0QFI5M1E7T0IX_?H5.@!99Z?SF71]D;
M/))</UPX @ ^B<H6M8U43-[5^9>YBI'[1P_RX [P>@J*@H<AY5_B1@<P:DKH
M(TZ9ZR*5L< 2"K3ELJ'S QMIF CHC$E\\)#OG#'?I0H<PY5T!SX_;1>N$C$J
MT:Y(-.P6J.3@[*&8PM3R&%PE.P##OUS1[9( +_J#7*I'3OUA*);".X/HD0+Y
M&3AV$*#BPP/.=5'.];AUQJ:#ZC ./8#ENPEDAYGWXUL/$6#1%\(-07HO'+9_
M>*V4DHCW(-87[U@"0$:3__[CV]\T7 2C46-BC."L:OR)])(6DG&M35.[=5N4
M/0AR##.Q6/;[ST?VR655SL&'Q%^C%GA%$HV./O_I6052E-A-Y$]?P#)=X5&9
M-BOGV%9@^%XUS)-AET(/26A=:Y7ZU"6-P[];#@LJ#(1E6X&RIW4K.BQISZ98
MQ4[,0&56$EIO2L9T5J^1>S2J2MIN$"1)-Q@#Z"[J& PQMQ@*27)S1'(>O0PS
M5OG^GF@NTC=RQ^+/R7Q<X52 [$A/P)3.V0CJ9;F@43T]/<LF3?/V#JQNRP$W
MG5BT])()N.&,6"^Z\;I:('_EE5RD0-:LS7 +;O\T7QT.D F#8,96X7T;JG>R
M4_7F21/P1JHUJ(<<JM7;55.[]6I\P/!(W_ZX2;/<5/A,-J&[H[L"^I/^[C,C
M<$&Q#A!W/38IOI!Y5^]UOV+'ZJ\:OWOX=_SNX_H^#TRH!,ZZNI6WZ .ASV\9
MN*+LEE?((_%KG0P:%U$XQ^=2C ,]*2FY4O9?BC@FN;1ND;09>4%!RRRU.D7B
M&QVB[7.=%;R1F056\&=D"'3<@\)G1#$06 U?UPP209])*'QP^$8J?G(=@[[Z
M$!.6-1<^4^G&,+*F6Q:/B,KV_9#D4P:%Z(FP.<:6'0C%!(FO\'%F?ANB9:('
M%BK+I\K/(,&ZRA%OHJT)O]YH$&>BZ\UYL,^SWMG-EYLG)A2*?7GXI3BW&#SR
MUS3W$2J)EON,$PP_,IX<NX.@&,I6DM9%O]4* _/70["(T,)]U2OH6W=Y*:W*
M%B 'P\+)JQNR.U2(=JGDZO?W;I'9'L=QSO!A#:\F)+2YR!]%2._OC4OI6X]%
M?2HAO;_W<:3&1Q;2JGT_G80FHO&DB,[^EM"?04+;77Y?\1S \6/Q?.O7-B6:
M[:S?02X73BY[I^OQK2-;*9)(]RF+U63=C)UGELERF.-P!>SLM-R"&WO,>/S;
MGC=,VS61&2D#3H9T% HE8;D /N6AJ(8]:PVK5/LPYOZ>@;Z'S%<:CAC#I]$5
MS ,RT2VQ)S-04XOFV;<+3'TB6IV']M.B:3!L>Y&].'I]M&,J\$XI^Z4B@&55
M5\OU$D>#J<#$=_?WR@Z3#E5WR35<9DC7EXCOQ^&*A+7#$D;<]HH"O4T;T]3I
MRM2-AM<*XB GS8_ERTU;P<C\)#PY6D795[G0(;(4'F8@9H2@%?YT8G'V+^.;
M0T^GK"@!)VNO%_;WFG5/P0*"X'730@HCX+3!M'LLF*[XA9P,Y@IW+MNFZ@OW
M"_SJ4NJ?:566Q04,&O&>"'Y%E!9?3BQ#%1B<4WF%W%\!3U="<3MWF0T&"K(R
MC6FJ*VT1)!'E,OM]/;M8"H0E#D@OB[=(0H8IAN6*>7J4UQ;>-KL2FEO;S2F"
MS<<)[G%1\>EA,087,Z*</Q$PYO3D]>G)V<G+<^H#=98A/.:WX]/3XY?4P.Y6
MNM4]8)3,:<+\^VW,_..HT(G+03LER<40!L(LQ\R4T3A818I;%:P_(<U6@T_
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M"SY]?<44"FC9N_.G"$8E462FHZ;5" ,3S&[TG/@S$LQD3O:_4FRR$9^^9QJ
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MZSW5Y>4:QJB[+3Z'.2*V8K983BK:W:K%>% [+W!<N,QY=M'B[98?%MSYD#]
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M&;KI]N0JJY?PNW7+B6:)Y#$6!44HDK]&2=&,V-2<Z5-P]3.W_!@*4$(!!@Z
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M_',M-"@^] +610_086@87F' BC$.)R N<=XEV0]LPS+A 18Z<G" SXK^K3!
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M/0%[PMNR6DZPGHT1D%2O$%7 (9YY4EX6B_F@1#6,A0OCNR[>!/3!O.H#UH6
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MI@TK]!DK$QMD=J,V:LKLWJJT,H[QI4/3RZ7(2&)B,X$V$)FP:^C37PB/)NS
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MBV8GL!B>L&*AI@0&A#P]G6^FP98X.7MJE@?][!N+VZ?1.0YK6^+?22TY+[R
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M[SX@]%$733.3G)NKS!]95D6PJ+)_V1#^G:$-:=*'V"DU950^,(/3QWUQ+PN
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MP HK>&)1G>,BG"#;RC-FSB\W1OVLZ?M.:&\R8:::Q649[ *K49/#V91A<)G
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MNE8&D_0+1]:7?3>5MMLW\2C>CYW]E)=E7-YL-^^5HG.4@GT&:L4N;DPRG.-
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M"C5GL^#W2*RSF"A6:\:2.H,F$<BB2,)0&-' 4*PQR)(, TX2.K'N?SB>0&#
M8:W]K>2L28Z!64A\!$6)RJ]1NT*F.#H'YIACII^29!>85,_GV@;)51:]B-M:
M?G=;Y@L>" GM=@G8PI5H]=!\Z1.]+1S#23@4*^M50/$PC?[,"XQW]VM;QAMB
M@R@YTX7R$Z-1E^=@T424Y>HI*J&-3C>0!@TM\0,E-\<\T\_(ZS'J74C=S$YG
MK05RYN*Q/F4]BXU&:2M/^IKW8,E !\-:M'&2P6UDN(W].A[B^QHX%XT*9?ZA
M:S[:,W4;$#B+DF/?4\[N1M2;H+N^UE%N,C (AB9'43*[E;#IS#'Q9(%*_I>D
M+U)VL[$AXDF.H(K!QO/JO&4/^] >%5M#>(48**X,Q@5LNZVY[(CJ8<:MA&'O
M/OHV'*"\ 6I;H@S"CZ=Z):T]]:D8J'*P;"U2OO*J;BU6LM*=*I,2CV0G3E#+
MN&VF;$^51FN:;&2S%53R;@=7,X9M6[HB%^AV+:"7:;,<TA_1#1!-7'1YD+J3
MFQ<%FL.&]&69UV Z+/A5;5T;I(Y-XCAJP]8!;:WLR3MWW(3!\[FZ+_=?9'B?
M^+IM/7E'*<O3YS1!YRQ@'4 Y+FOE^S;[6PJZ3<66.=-<1RB 7P_0?_9BY3^[
MW73'&D]LH)(N4,R<U6$T+N8>I (M2:=>VE8QCPWV,<GSFG4 PD<. 57P,S%'
MF7;$FZD0$Q#?PP+$L:;*5E-4XR^(YM& %W->#&,-L3!E<PJ="552S:O8P18L
M]!9E>?:8#0#KEO12Z,^BPN0,.K52-@/6"&V/D_FP3,9)5'"N YLH%X9)XKI>
MD237< JRY2HW50D1/^6JC4V+V-LS\";X91M8$*/S)#IWX[IX8SH[8CRW/C0]
M7!9COK*R+.MV"X!U8R0LIC&8E&.Z6(]_Z*>FFX1#+U^SK]J%I8-7[=VP<R+&
MW=8BY.YUK!'YV-7:MVD12R;$",@6.5KAD,7QN)1Z$&"GZVM";NXQ<!P+Y@9X
MTFD]$3>LJE6<]H ,*I1F_XRS(>I<V)I;.5>V5SU%L6U/0U=DZ%7J+H72WUI^
M6R,SF'G-=/#7IQN@ZNX)9TP^MGI-1S?*L6A(5#FUP9Q5HM:2RZZUIE&*ZE]I
MJK= 9T(77CX_ W/HPBA0KL\.\0;<_L2H?["I,(2YJ.BHMY7HG*&QHF(IM*A5
M>U-_QHHC\ 405\0 M76,!<R#FBA$N[@I"S=(:]1Y$PA(G@PV=F3XPQCLM[#I
M1VPWV2UA<DB%R'$@XF"BZ@I$^67> SN29P-3N<!?RJ)WNB<Z1U W.*] A5;3
MN<2#&+7X=5K5;ZJYZ[#+>E65I,N+N/%.#Z2F/HB?QL^BAPO%T8@1;>,K-&X!
MKT.&',9>4Q'?BUF_]7=;K5TM>5NF8!U[<^.]F= UU;BN=0T#NS2$!L(A*<:C
M,U=K$\QY?;C\K#63PJ7#&@!]-,=P2,$9<L ,WPS?1G.0N^2BF_2[C/KGYY,7
M/<IQ8J5<>9:6''8"5T/U8;F)@,!:,!-QXY? =,4D%C9C#LGR18 VA&@TP(5)
MV6+T,URTU<'XO$D[#.,:P/QS1GX)E?)H0]]@2\[,[BHUE)_&)V?D_,,-R$B:
MLDN#CH-_S,$&LO<04%X,O)+R?A'WIO;[Q*B[/9,E=,LHM2A??\(/Y3B1NOF6
MI2@HY .KFZEXBUL9?J!TMJ.% 6966YA\Q.6OC*7BZJN1<T5E&3'P'X/XX!)/
MH\_"8+"R*</(N,[^608S&7[SD"'IGM)ZF1)+J [(C1 U^A[9.#0Z8(15-S>)
M$:'41"-/MJ5N@02&_,078Z#YC '2<]C#VJ@%.=8&B<I<[+N:A.U;!Z)O#T.O
MI7-#4KEN/P:I@F/.-%,%H<>!!YGQ).+I(C(UB>G*9/+ZE]20%>BRL=Y>SW<X
MI52/\U@34J6"["EVJ#1G9Y04L#H8KH<GB!O.QDN CU/B%M(+*QW ^](X8E@#
MDC<72?<!P$.,^K@Z#8;161(!VKD G6;6B2[KE:_Y"0%I$J./^J%ZLEZN/%FW
MZ\D21[H].^R44.?=P\-NP* R+TXJ(G2Y8X@Z3!T_1L$@4,*H\<=C=0:G*X&F
M+:)^*0[[AM"GEVM@5DN1L7J[J.B:^VB_T0*W5'BK?JE@L5LJ-"XCISR8&)\Y
MZ,8\=)%B,JE(%,UY><E(05L4ID"5RXUDW([7*_R2YH.7?PJA,\'5A4!4$<E0
MCKJQQ/4:>>"LH#SHE 4/ TJE-27&<<\(?;4GRD;S@T81[!>M@D08<5VJE,6&
M>/\;CQBTY=7Y*U_$F%FG\R&4CR.-+N]'XMGOR^>#4UV'K]WGA'%'%7@,K@P?
MAS:9$.72N(@NHU3L<8NNA_H^Z? PUQEIC5^OS]=08_AD]^O)&PL4Y<%M:,I"
M%*91&!;@NKS.::Y0<N^0 B;DDO1<&BJ@'>JT 2_'Q8*7G\-PXM"54:!+ ]D+
M'!3.:;@B9Z1K;]UCU=-%C<"(#B^W:OO$DS ]89[&@H/L=-<;ZMP^@VFN$[M]
M',RR V 6X-(%=^KL,LZ_4ACX+C>$[9.NU"OG'ZLC5QEVZM:C)9[_1O66]+LW
M@#2;B@C4.<6&9>_M?M@Y#LJK$B_;X'8K(]2H\\)LW@!T['AL^C6X"<$ZS\ZO
M2D2_H!23NS\)9X-><+1ZMV8CY;@I-Z:G40*L3240QV<C+M$D\_:L0]AAOX<\
M9\T8$9.TYY3:BF(Z$XM3XNO 7K61+I$>"?(8PP]@'#CB.V.QJ[P:H[B[L^^S
MC?'=MTC;.,?<%W'[LN&\H$H!-SVR_/ :954VCP->QE*'=*51GL_BP@,46'+3
M_<SA8K&L6WC38$%$9'W-%7@T8RTJ*Z7T?&CO4C#J3SY?H?;C5#TM-4N=%OE[
MEB"O(QE1FG1TFVEEHP 60=?Y?$.;"T1GZ#H+1&2-JS304#LV9+>^UIGY Z\<
M2S=2OYO3J!(/(KD)U<@]]T/,A%(/]IK8IK]*2Y_JGLSJ!MMO1O:8;:OVW#!.
M0[)2CI=>R<1MT]8690B=X9A26'G0K*5Y&%6]6CVY9BEJKTX5??%Z#RSU#O/@
MW'3_,4.W10OH0HH+TYICAIY+F@=C2#3>]'"+Z'Y:N4Z^J1!)FMJT$Q$U!J_S
M1C$_%VS0-*DXTQ6.'/JZ*8".Z81\<BDCGGOVL!6/\&'$QG1A.3*JWJBP:_M#
M+N%*X!KCN(8,V65ML3[HO=QFT4_@,6%-:?;Z'E,@N-$!+92<%N0T@KH)7#>-
MS[ 0.C3<53AD7RLIB[ I7:BSW+BM2@&NU)D.[ "*IDZZZ$U!MYALY3TPU?\$
M4]VT$>J*EO3VP4$U*UPFL<Q*;U!J/2]W%7WFK'TD#ZZQT-S:%#*YE'YX0PF<
MU'KPJ9L/-G6*F?7"VO*#:SGI6.&!80<%X6PDW@R]*A5"&8T=JI'1)&@50I>"
M6XN!J^"L*NFIA7"!YRN@J 4!8$\?-O4N775&MG#H9B9IZ%*+G0_+"FC[$ANS
MB22*P>JY/?PA:!^,0-J=E)V9P)T''*A0Q:/L*T,U#R!0LXFL7).EE]>@5/)Z
M8O]2^31U!#8\G4$TS"_BC@R:6G9'7P:-25Q1E_M)-:&4[C9]EN;%[=:K#XMY
M73B).*/#:E7-]M0@"VU2S@4'7?,KOSJZ#?MV&'O^6]-/#@<)TH4H0P&/U_;@
MST%]]9<.3."A5-.@; F34"GN;D[3$]"U)\$(#"?$ </TGM*F:2EO"?'(T5S
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MJ,ZDMB]"8V6YYZQ?V(&U(BT<I,R!-^%S46T.,C@39>?ZY"JP2T%,9M>M0WC
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M28E(KV? N68X)%E$J895&1_<*:+Y<'X<C+/O:1I+C'U!F^MK^STPX=:G9[M
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M]I:DM(0Z4,A3M#\-/*BHM(59C15TCT01RTE26*L$3(+Z856&I=WUH4[H4'_
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MM;CVZ_UUKBF,55>JU89?XQ .;_\0'KMD;NDJN9%,;#]&Z@P>8?V:2</'D/C
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M/DP@!_$&+7.I7QLYX8WK;\?!^&AG''\6ZG,WB.-@Q(\&@1]O1^[_R:/=Y//
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M(8%O!Y.0I%11K00RQXN50#.,QQ[-#!-I<;YS(RE&0=\=N/!T'+KPA1)?7%'
M*S(8E.B!T2#V=Q<T ^A)ZY_.:/RY-2?IB7;1<.'X"( 2+NHEA0R<7.O="+07
M"-<4-,.#-X$##>QSZF@&Z,4P G;'DS":.(!S&'LW=$$IX5@MD"2##@[LXPLC
MYR]I".[T;T%=2J(+V [)VX&W0"G </W>^EJB5YU>+Q@!W YK5GC72#M,B N#
M%9KX,6L"T!(^?!/)&!1)B%K>S]6NK#I_INHZ+:?5%!#0!P!'@",V5R@7ZVOZ
M#43UX><(;*8?!9[+[-R 3;7DK?0G$C='^ZI*P!1\=RF!&?N@^OK(:0G+[^\R
MRXL[6-(#4X<+,4HN7-\=34:9:3M#8)YAX &W .>X/:?K\5ID26<6 ]3>NH''
M%IV\A1[^R0L?EG?Q61[N2XII!H[K34*YOH:[)-LID8C"OD6$P&!8SYEXL9@@
M8V6G!\=T=]/96K0$.CLI;FY/NG_"Z+F94US]\QFB4D[H31P1RG]/0'11<)&5
MF2_PKQS)0F<&7)PMQL:=X\(WN.5%.RW!R_IM4A1&),=A<.M&[+4P,I<J+(8/
M)M0STAQ]YA0'9I1C9SI2 .",1C4CVS.]X77E"VI6=@SQ8%3.YD']N7X)N8[\
MH)X32?J$"B+LHUIAOP[G @=@Q HA4@A1:AJ6AJW0;A,=P5._BC>5N.JOX4XU
MFM?@277.[99]UFS9A,XL<10! 4_R)@">*,V@-Q>?I'/=:)9AV".^"0*V1;>.
M-R']DEF1%PAE3[KC6%%P,'![+GC"4P2'=0?Z_MH@]O[R@SM/]F]0+-@]%/G>
MH1J 8($-!2L3>.!81T?WR/[AC\#[;EEP@*LU*@I(]!G4, 0JCA?I:+0L.AD\
MBFCH>)Y(]"5(VQE;2A#7:M";C+38(!;U=/0 A69]S005B\*.$FA;LA.)PR._
M@T1'D3<5?D#:Z<X%(,#SZ.,0,M^I:?.T<<HQ9AJ41<49(VR L+YBITF$?O,D
MQE52J_<5BEA(%09($^)2(^GXL'>8/^J%;I>A@2]&6<._OI8R#:[?\R9D)^-A
M "OT\D%1$Q@D(@!Q\ J&8D]S2]T=N>@(7*.Z#Q,F:6=U7 2"% T<LI;K:TJ"
M%PDJ3*L,*\V'4])_6+&_QT\Z_$0N@A&A]%S2MH&O9!79 W:F/#1\#6+S$!Q$
M#&]A8;0SC-#[5SM(KY98@(QSR2*\W."!<>W UYY"&0V8\PM!MNZ':(\@@M?D
M8(!OP:+@CTD0!6VUP!<> Q/-FQ/67<2MW00.0%4/N!HF )FX@Q &W-[4F\#Z
M$.9_[\DQ"4TB><K"]HT9S(@?>$(,+SQUV+Y*=L\=?\JBIQPO1@/ SI% SVAY
M?!&9'[\SO++0O<* B,>P4I]70I_%9M=X!_)/D#?@&!Q 248. YG$RNJ^J]:^
M O)54G1]3=#_C\<BBJ>>S(J9',U)&3X:.S=RNQM*YZ_MKD23=>1X=\XTV@!Q
M?3?&1<Y;HEW[;Q#:_0T]+R5MC_[VB?ZW(:YKU<[Y;QN[.SO_,/:Z O;9;JU<
MVA8F!SIDG$,D+$2%]+?27X-)#$ZV\J&#4)EXGWD^\9CR2+R$OCU%WXPY2O$>
MS*#YC7EE[&"&3FD+^!H,, .G'7T8,>?\;S($)FQ9)/!;2=(M$Y70PG,^[F.W
M"\9YLZ_W"QP6,S,'72 V+P4;!I;K2B=4P;7S%TZ ;TD,]7K*%!+>2T0Z'1WC
M.SJ*IT#8@-HC,#\C=)M2+8_1/2P;#1';DPA8AV46@G*)8_H2.!!7IN0L09G9
M\R7G'4M:?T,8#@SC@UV':5@D%3*8M9(7"4!\]5Y7^<<8P7UM!).<$:#O ;F5
M!48RUX4E1&4=5^,LE$A6@@GX$J3,4]YJ:@9,96A3X:,;]51C2S&.(IS.%+,'
MPOXK+<61W(-B-DIWI=W=!=1[B+_[Z;'$PTA=;5SL)HF!Y4"[QN*G$JM.7SEO
M4NT(/Y&;J(B@\T)CD/MQZ)*P>N.ATY4Q6#P/9:]/*H5LZ5.\?_4(=3QAXUFL
MS6D*DZPX"U 5)+G15'H0O=THFT+-^H2<.)C/JAX MX /_(()7E+%$CD_M9YM
MO*0JO#I3)M)AV"+7#KE\RD2) 6[>\1,X]6?29F;'<Z0R!30EZR*1>?R/+J@]
M8+</TJJ/%\SNED W.9$>I"UO]][\H (8&#";EGN6<',-3J>OYS36TT5T=_^9
M=+\7%W-4-^XX!@E<M$NRJ;D96U!)/EI==EOAG5ZJD*-RN._9V(QR0.$,>,K6
M!&QK>D/9G\":A^5=XCXGCAU\IBW)@LRNRN]U'[L+X0S K"Z$WLF#'>L;!'Q?
MHDFF2;M3I2* O;!*"_Y6%/BT;M^%.%\2HZI<%;A^3N+*FEQ/*Q65WDJ=3X<'
M+OG(/H0*)E?2=3#>QU2DJ3H0"Y+C1V^ (?F3^3P"0#U4M1QY&3AGLY 9L3@H
M[^JDMRI6K*^9T!!B/J[)I$L;6? S&,&H$9'-'&.*4!KK8G_WN'UE)"7A^@_O
M00@ <+*!VQ2E'($ ;9Q$8&)@Q(F6W"GZL(JBF1H7?8$0T$[R2@(P"CSEX]J)
MB5>/W]5.R&#!.!]LD+Q-\EA+V'F@W-!GL1T%WZ;N@?_GR>6_)T!FM;$;\N@I
M3MG\KKA>>1!ZY275D@3B^:H,;)KA5'ZT!V$0V%+CE[LC"./12Z$X'W9!+X/-
M!#8B09QNB;^_WRGM[- _:6/QC#34XVU%+W'B]LI[F\.M):H^G72;=^0RJEX)
M.G9+@'1/5T#UX_9 A5XFM8PS*5&)ED6-@TI5RU21=:;,07TT5 9Q8:,Q)U>H
MR$K2$WA21>+H\Y0,H[.> W-#Q8#-NR%WJP#2;@,/^,L)IQSA^^")8<]+JM("
M+R4.5E?/I2D4],"SXP0MA<3S87:ZQ$V1H#M3NC&YK%XPDJCNI(<I>]E/)531
M@ -B)D )T%N]Y"WDF?[$))V7@].7.I\[YV)@Y6^PM96!F-MR< 72ULZ49!:&
M#B:>5S*8B=0FX 6CO$M&:KL0L0U< @-?TGXIEI\Q3Y=4LQ.<Z'HVQ/,.O3F&
MX#U;UNH%44P>,^E+/>F(LP,#8!ZP,+>.ZQ'$*1,0&<::J:2DJ3Z0<J;4.<NP
M2>,2:/W>Q-/B-E\U<[$=JALQKLOD%F8G2[*91GDBJRO=5Z3Q7DP#K:]EG2&P
MIR,0"G?L38%IT**F^AZ 'FRH6=ML MMA(=E5#@I02WU50I$F)E0#@>#*\&WA
M$MVIF3D)JU,6<"Q#+%P"<=0$1XFQ'$!<I%]87]L\* />MXP(#-P0+!YY#\G,
M^,62<*J$ID];8ZS9J17$YGYV@8@#T:>L0 ;V__0J=T&RQAZO00$I>1CWR 3X
M<" (@*NI2GQB(CZ*P.\ *DS&@:_2D&8H-5FF='9DB*/>B 0\E0F&#4V-*\C$
MI8G2#3D99;E'71)8^M\\W4+Q1H.#?0-B,Y28(T4T!5A+!X&.*5':D[(?;9$)
M2-Z?':"!!-?F.P[0Z+YPOI.75'?N0/.*%J!XBZ@XRY/W@WV8:NV8I2!!9BA&
M\Z0L2ZK30,D%"H4R!-P["4X'&;P!_3TPJ=Z\7@4>EG&"+YR8DB3K:\A "3G(
MA@MK,' ]RCCI)H:RL&"* 6;LM%U*[YOT+F#9N0F=\3!1L:JX@^M/MX&O?>4R
M'9\U&QVCL(9N++>CL=.31WYP!S-LG/B!OPW; N.!:QV_P_=/4DF;BA=$E-D&
M(,O'VCR@H7B%]$,_<2D/RWO/R0L^RIU\1D;IJ?[D3'/4'CJ7.J:H.-&074N3
M.:B TR$57_H/T60ZE0UXFY#BCLF)B0F:1(>5DIZC*-%=J/3 QTG"SRL?<1FZ
M/<H0 GBEM!NK9#@)JQI@J2!"\CPD9!4P[<#LFW__I$.6K5>+6< SU%F0];7#
MIV6G(."7L6&QL>=@2[8IG*63+',)%F \?93"^OF- P=E8'0JFK1R:O37ID:/
MC2<.**YPE.[EXU1PC9JI(U-(@?FHM5_8F!&:;:T!!L1I5(X:N4OA>TF3P-)^
M36KXB<.)YG.('GJ<=X$U1NC#8-8&EAC#<S!+FZI8 [:!')AT-5"_CMM#1Q:S
M+Z:9%!%NO/4LU%S0))C!H!$#J 51(&B P4>B;U.-P;JRKRP)E?I4*1SA6K*D
M( .L"C\"U\4"/L^ODS+K:]@6MW0F8V4>C%'QXQ'J)%$2V#L/I\"]E<6U6IG*
M;DGEQW2D<6>30;U9(\-ES)*E?,) Q!P@[V42,<KF4]=+Z@M.-MVXMP@)U_J,
M'4^%:7Z0TX/),V8X16<F30];*7D=FT)5J,S:QXU2*AZ$NP%0(QBJX\1%ER5F
M>PCKN"-P?JCF3YBC3=\"=?IT&(8VB!0+0LV)VF5)LJ5*";A*"9!+1$V9KL1R
MJ9)55/CP@N.59[1"JC6/B:%+E\CR284SB[E\\4^?NEE?RRG0)\WH+BEO1Q64
MTLW%!@.<]G55^C#=!(#'>,*);D/-D*JD"_GDQ#DW#KX[(_<YD35GL$F,J&D)
M"\_I)A]2!7IBEX0H5OI"=?CKYJ$N.)U=Q_\KG(SCWA2325'@W7)CI.Y]B.!=
M,+_"<^XBD7;94\OHW7%W01!&3'!NS8&@4/I(3(^+=Z#5U0,,^]V8/=C0!?2/
MP0-XA5: ][H5H)*IN]OINGO:7%$V+;>14B6SDN:N&>T0Z%QWNAIO DQJM-(
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MBKBS25[-A  )H8>_!& ZN/_..=% B2J8BGV-1_[=B?6UK#+4>V@W&>B4WKD
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M!(.V,R\O#V^!=WQ:.XN#U--WM3,R4EB#\< ENDN25TMX>J!<SY5XCR)N77W
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M0@:P]?<A*PSE@%!].UU'C*N#?A RP;FT#@9=>DA,E_/NL*AZ@);=B6CSP#V
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M?K=8:(&T-QM HX[9_EJKF)J&6D<0YCJ\7A[!M,G4>WKLE?$-$7)E5$UQW0)
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MMR!EC9.R!G^;]/MZGSWP-&"W7%/!TPS0;ON*;LDVV\ZZF_OT?V<P:/['S?\
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M];E2O'ARHZ7D>\'1,%"U)[&68<;$4<.!A!*$K1RN4KA:8\<J'KI*XR7,71V
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M9?]$#2P"2\0FY&(CBX,/A\X9XZ+(]M;7)Y-)#X;OC<S#P?J'PV]9:>;HS$(
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M K6+W,0\?O$, (5=\YLPOI_S<A@.*108X^!J" 'KZ[E\FT^C7S/@?;H/>B[
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M@_,SP Q!Z^XPI:V'S#00HD&C&08\519ZV'!T/'6W7[.KP,85MW'VJ2P/WS!
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M<7G\_4Z_N[FUW=W:>+5449_;033O\;5O]>@'?/SJY"<\Y/\U[;]02P,$%
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MZ]G.BO2?1_3]#?KU+ ;Y1[?_ E!+ P04    " !]@S-71+9$E3P#  !*"P
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M>C%X.;V57"Y-^W881Y;R+GOC^9_#K0P^-%R"6%KNH6R;H_[2TWIP\-[/!6F
M/WR;G&Q\'I;O W/\1BM=+AJ.1SJO_0O4?;]7Q2=%S!8GU%BF#*PB$/203$C]
MYT[J2XX=RP+IKYL(W9L._(?^V746^D>N"FC,0<_> 5LWLFZ_MEA\5H?AG'.9
MUW*9\Q;<:FP#KE=K=^0ML\VX]K:K5S?%;'V,VYO^N#=7S;JAGW\ 4$L#!!0
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M @ 1              "  2Z8  !D-30R.#@U9&5X,3 R+FAT;5!+ 0(4 Q0
M   ( 'V#,U<BCSILLD\  /#; 0 1              "  = ; 0!D-30R.#@U
M9&5X,3 S+FAT;5!+ 0(4 Q0    ( 'V#,U=:@[Z9%B4  *0/ 0 1
M      "  ;%K 0!D-30R.#@U9&5X,3 T+FAT;5!+ 0(4 Q0    ( 'V#,U>N
M.WT6&2(  /;H   1              "  ?:0 0!D-30R.#@U9&5X,3 U+FAT
M;5!+ 0(4 Q0    ( 'V#,U=0'8]V/0L  '@C   0              "  3ZS
M 0!D-30R.#@U9&5X-3$N:'1M4$L! A0#%     @ ?8,S5Q,Y!(XC$   H38
M !$              ( !J;X! &0U-#(X.#5D97@Y.3$N:'1M4$L! A0#%
M  @ ?8,S5Z9@LW )#P  >RL  !$              ( !^\X! &0U-#(X.#5D
M97@Y.3(N:'1M4$L! A0#%     @ ?8,S5T2V1)4\ P  2@L  !$
M     ( !,]X! '1K;F\M,C R,S Y,34N>'-D4$L! A0#%     @ ?8,S5UY"
ML/2,!@  JD8  !4              ( !GN$! '1K;F\M,C R,S Y,35?;&%B
M+GAM;%!+ 0(4 Q0    ( 'V#,U<G 3"ES00  #LL   5              "
M 5WH 0!T:VYO+3(P,C,P.3$U7W!R92YX;6Q02P4&      P # #X @  7>T!
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
